<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1308233980
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2003
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MEDROL 4 mg tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        METHYLPREDNISOLONE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        4
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        19.5
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="PFIZER" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            PFIZER
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            PFIZER
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        D07AA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine contains methylprednisolone, which belongs to a group of medicines called steroids. Their full name is corticosteroids. Corticosteroids are produced naturally in your body and are important for many body functions.</p><p>&nbsp;</p><p>Boosting your body with extra corticosteroid such as Medrol can help if your body cannot produce enough corticosteroid due to problems with your <strong>adrenal glands</strong> (e.g. adrenal insufficiency).</p><p>&nbsp;</p><p>Corticosteroids can also help following surgery (e.g. organ transplants), injuries or other stressful conditions. These include inflammatory or allergic conditions affecting the:</p><p>&nbsp;</p><ul><li><strong>brain</strong> (e.g. tuberculous meningitis)</li><li><strong>bowel</strong> <strong>and</strong> <strong>gut </strong>(e.g. Crohn&rsquo;s disease and ulcerative colitis)</li><li><strong>blood</strong> <strong>or blood vessels</strong> (e.g.<strong> </strong>leukaemia)</li><li><strong>eye </strong>(e.g. optic neuritis, uveitis or iritis)</li><li><strong>joints</strong> (e.g. rheumatoid arthritis, rheumatic fever)</li><li><strong>lungs</strong> (e.g. asthma, tuberculosis)</li><li><strong>muscle</strong> (e.g. dermatomyositis and polymyositis)</li><li><strong>skin</strong> (e.g. eczema)</li></ul><p>&nbsp;</p><p>Medrol may be prescribed to treat conditions other than those listed above.</p><p>You must talk to a doctor if you are unsure why you have been given this medicine, if you do not feel better or if you feel worse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Medrol </strong></p><ul><li>If you think you have ever suffered an <strong>allergic reaction</strong>, or any other type of reaction after being given Medrol or any of the other ingredients of this medicine (listed in section 6). An allergic reaction may cause a skin rash or reddening, swollen face or lips or shortness of breath.</li><li>If you have any serious <strong>fungal infection</strong> such as a serious fungal infection in your lungs or oesophagus (the tube that connects your mouth with your stomach) or any other infection which is not being treated with an antibiotic or antiviral medicine.</li><li>If you have recently had, or are about to have any <strong>vaccination</strong>.</li></ul><p>&nbsp;</p><p>If you get a rash or another symptom of an infection <strong>tell your doctor immediately.</strong></p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking this medicine if you have any of the following conditions.</p><p>Your doctor may have to monitor your treatment more closely, alter your dose or give you another medicine.</p><p>&nbsp;</p><ul><li><strong>Chickenpox, measles or shingles</strong>. If you think you have been in contact with someone with chickenpox, measles or shingles and you have not already had these illnesses, or if you are unsure if you have had them.<strong> </strong></li><li><strong>Worm infestation </strong>(e.g. threadworm).</li><li>Severe <strong>depression </strong>or <strong>manic depression</strong> (bipolar disorder). This includes having had depression before while taking steroid medicines like Medrol, or having a family history of these illnesses.</li></ul><ul><li><strong>Diabetes</strong> (or if there is a family history of diabetes).</li><li><strong>Fits or seizures</strong>.</li><li><strong>Glaucoma</strong> (increased pressure in the eye) or if there is a family history of glaucoma, or if you have <strong>cataracts</strong>.</li><li>Contact your doctor if you experience<strong> blurred vision or other visual disturbances.</strong></li><li><strong>Viral </strong>(e.g. herpes) or<strong> fungal</strong> eye infection.</li><li>You recently suffered a <strong>heart attack</strong>.</li><li><strong>Heart problems</strong>, including heart failure.</li><li><strong>Hypertension</strong> (high blood pressure).</li><li><strong>Hypothyroidism</strong> (an under-active thyroid).<strong> </strong></li><li><strong>Hyperthyroidism</strong> (an over-active thyroid gland).</li><li><strong>Pancreatitis </strong>(inflammation of the pancreas which causes severe pain in the abdomen and back).</li><li><strong>Peritonitis </strong>(inflammation of the thin lining (peritoneum) around the gut and stomach).</li><li><strong>Kidney</strong> or <strong>liver</strong> disease.</li><li><strong>Scleroderma</strong> (also known as systemic sclerosis, an autoimmune disorder), because the risk of a serious complication called scleroderma renal crisis may be increased. Signs of scleroderma renal crisis include increased blood pressure and decreased urine production.</li><li><strong>Kaposi&rsquo;s sarcoma</strong> (a type of skin cancer).</li><li><strong>Muscle problems</strong> (pain or weakness) have happened while taking steroid medicines like Medrol in the past.</li><li><strong>Myasthenia gravis</strong> (a condition causing tired and weak muscles).</li><li><strong>Osteoporosis</strong> (brittle bones).</li><li><strong>Pheochromocytoma </strong>(a rare tumour of adrenal gland tissue. The adrenal glands are located above the kidneys).</li><li><strong>Skin abscess</strong>.</li><li><strong>Stomach ulcer</strong> or other serious stomach or intestinal problems.</li><li><strong>Thrombophlebitis</strong> - vein problems due to thrombosis (clots in the veins) resulting in phlebitis (red, swollen and tender veins).</li><li><strong>Tuberculosis</strong> (TB) or if you have suffered tuberculosis in the past.</li><li><strong>Cushing&rsquo;s disease</strong> (condition caused by an excess of cortisol hormone in your body).</li><li><strong>Brain injury</strong> due to trauma (injury).</li><li>Unusual <strong>stress</strong>.</li></ul><p>&nbsp;</p><p>Contact your doctor promptly if you experience muscle weakness, muscle aches, cramps and stiffness while using methylprednisolone. These can be symptoms of a condition called Thyrotoxic Periodic Paralysis which may occur in patients with an over-active thyroid gland (hyperthyroidism) who are treated with methylprednisolone. You may need additional treatment to alleviate this condition.</p><p>&nbsp;</p><p>Tumour lysis syndrome (TLS) can occur after treatment of a fast-growing cancer, such as blood cancers or solid tumours. Symptoms of TLS include muscle cramping, muscle weakness, confusion, irregular heartbeat, visual loss or visual disturbances, and shortness of breath. Your doctor will monitor you closely, especially if you are at high risk of developing tumour lysis syndrome.</p><p>&nbsp;</p><p><strong>Other medicines and </strong><strong>Medrol</strong></p><p>&nbsp;</p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, (including medicines you have obtained without a prescription).This could be harmful or affect the way Medrol or the other medicine works:</p><p>&nbsp;</p><ul><li><strong>Acetazolamide</strong> - used to treat glaucoma and epilepsy.</li><li><strong>Aminoglutethimide</strong> or <strong>Cyclophosphamide</strong> &ndash; used for treating cancer.</li><li><strong>Anticoagulants</strong> - used to &lsquo;thin&rsquo; the blood such as acenocoumarol, phenindione and warfarin.</li><li><strong>Anticholinesterase</strong>s - used to treat myasthenia gravis (a muscle condition) such as distigmine and neostigmine.</li><li><strong>Antibacterials</strong> (such as isoniazid, erythromycin, clarithromycin and troleandomycin).</li><li><strong>Antidiabetics </strong>&ndash; medicines used to treat high blood sugar.</li><li><strong>Aprepitant or fosaprepitant </strong>&ndash; used to prevent nausea and vomiting.</li></ul><ul><li><strong>Aspirin</strong> and non-steroidal anti-inflammatory medicines (also called <strong>NSAIDs</strong>) such as ibuprofen used to treat mild to moderate pain.</li><li><strong>Barbiturates, carbamezipine, phenytoin </strong>and<strong> primidone </strong>&ndash; used to treat epilepsy.</li><li><strong>Carbenoxolone</strong> and <strong>cimetidine</strong> - used for heartburn and acid indigestion.</li></ul><ul><li><strong>Ciclosporin</strong> - used to treat conditions such as severe rheumatoid arthritis, severe psoriasis or following an organ or bone marrow transplant.</li><li><strong>Digoxin</strong> - used for heart failure and/or an irregular heartbeat.</li><li><strong>Diltiazem</strong> or <strong>mibefradil</strong> &ndash; used for heart problems or high blood pressure.</li><li><strong>Ethinylestridiol and norethisterone </strong>&ndash; an oral contraceptive.</li><li><strong>Antivirals </strong>(such as ritonavir, indinavir) and<strong> pharmacokinetic enhancers </strong>(such as cobicistat) used to treat HIV infections.</li><li><strong>Ketoconazole</strong> or <strong>itraconazole</strong> &ndash; used to treat fungal infections.</li><li><strong>Pancuronium</strong> or <strong>vecuronium</strong> &ndash; or other medicines called neuromuscular blocking agents which are used in some surgical procedures.</li><li><strong>Potassium depleting agents</strong> &ndash; such as <strong>diuretics </strong>(sometimes called water tablets), <strong>amphotericin B, xanthenes or beta2 agonists</strong> (e.g. medicines used to treat asthma).</li><li><strong>Rifampicin</strong> and <strong>rifabutin</strong> &ndash; antibiotics used to treat tuberculosis (TB).</li><li><strong>Tacrolimus</strong> &ndash; used following an organ transplant to prevent rejection of the organ.</li><li><strong>Vaccines </strong>- tell your doctor or nurse if you have recently had, or are about to have any vaccination. You <strong>must not </strong>have &lsquo;live&rsquo; vaccines while using this medicine. Other vaccines may be less effective.</li></ul><p><strong><em>&nbsp;</em></strong></p><p><strong>If you are taking long term medication(s)</strong></p><p>If you are being treated for diabetes, high blood pressure or water retention (oedema) tell your doctor as he/she may need to adjust the dose of the medicines used to treat these conditions.</p><p>&nbsp;</p><p><strong>Before you have any operation </strong>tell your doctor, dentist or anesthetist that you are taking Medrol.</p><p>&nbsp;</p><p><strong>If you require a test to be carried out by your doctor or in hospital </strong>it is important that you tell the doctor or nurse that you are taking Medrol. This medicine can affect the results of some tests.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding</strong></p><p>If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine, as it could slow the baby&rsquo;s growth. There is a risk of low birth weight of a baby; this risk can be minimised by taking the lowest effective dose of the corticosteroids.</p><p>&nbsp;</p><p>Cataracts have been observed in infants born to mothers treated with long-term corticosteroids during pregnancy.</p><p>&nbsp;</p><p>If you are breast-feeding, ask your doctor or pharmacist for advice, as small amounts of corticosteroid medicines may get into breast milk.</p><p><strong>&nbsp;</strong></p><p><strong>Driving and using machines</strong></p><p>Undesirable effects, such as dizziness, vertigo, visual disturbances and fatigue are possible after treatment with corticosteroids. If you are affected do not drive or operate machinery.</p><p><strong>&nbsp;</strong></p><p><strong>Medrol contains lactose and sucrose</strong></p><p>If you have been told by your doctor that you have an intolerance to some sugars, tell your doctor before taking this medicine.</p><p>&nbsp;</p><p>This medicine contains lactose produced from cow&rsquo;s milk. Caution should be exercised in patients with a known or suspected hypersensitivity to cow&rsquo;s milk or its components or other dairy products because it may contain trace amounts of milk ingredients. If you are allergic to cow&rsquo;s milk, talk to your doctor</p><p>or pharmacist first.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p><strong>Steroid Cards</strong></p><p><strong>Remember to always carry a Steroid Treatment Card. Make sure your doctor or pharmacist has filled out the details of your medicine, including the dose and how long you will require steroid treatment.</strong></p><p>&nbsp;</p><p>You should show your steroid card to <strong>anyone</strong><em> </em>who gives you treatment (such as a doctor, nurse or dentist) while you are taking Medrol, and for 3 months after you stop taking the tablets.</p><p>&nbsp;</p><p>If you are admitted to hospital for any reason always tell your doctor or nurse that you are taking Medrol. You can also wear a medic-alert bracelet or pendant to let medical staff know that you are taking a steroid if you have an accident or become unconscious.</p><p><strong>&nbsp;</strong></p><p><strong>Adults</strong></p><p>The normal daily dose is between 4 mg and 360 mg per day, depending on your condition and how severe it is. Your doctor will prescribe the lowest dose possible.</p><p>Your doctor may tell you to take your daily dose all in one go, split your daily dose throughout the day, or take it every other day at 8.00 am.</p><p>&nbsp;</p><p>Swallow the tablets <strong>whole</strong> with a drink of water.</p><p>Do not eat grapefruit or drink grapefruit juice while taking Medrol.</p><p>&nbsp;</p><p>If you are being given Medrol because your body cannot make its own corticosteroids, your doctor may also want you to take a second type of steroid to help your salt balance.</p><p>&nbsp;</p><p>Your doctor may prescribe a higher dose at the start of your treatment to bring your condition under control.</p><p>&nbsp;</p><p>When your doctor is happy that your condition has improved your dose will be reduced gradually. Normally the dose will be reduced by not more than 2 mg every 7 to 10 days.</p><p>&nbsp;</p><p><strong>Elderly:</strong></p><p>Your doctor may want to see you more regularly to check how you are getting on with your tablets.</p><p><strong>&nbsp;</strong></p><p><strong>Children and adolescents:</strong></p><p>Corticosteroids can affect growth in children so your doctor will prescribe the lowest dose that will be effective for your child. &nbsp;Your doctor may tell you to give your child this medicine on every other day.</p><p><strong>&nbsp;</strong></p><p><strong>If you take more Medrol than you should</strong></p><p>It is important that you do not take more tablets than you are told to take. If you accidentally take too many tablets, seek medical attention straight away.</p><p><strong>&nbsp;</strong></p><p><strong>If you forget to take your Medrol</strong></p><p>Wait and take the next dose as normal. Do not take a dose to make up for the forgotten one but tell your doctor or pharmacist what had happened.</p><p>&nbsp;</p><p><strong>Stopping/reducing the dose of your Medrol</strong></p><p>Your doctor will decide when it is time to stop your dose.</p><p>&nbsp;</p><p><strong>You</strong> <strong>must not stop taking</strong> <strong>Medrol suddenly</strong>, especially if you:</p><ul><li>have had more than 6 mg Medrol daily for more than 3 weeks</li><li>have been given high doses of Medrol (more than 32 mg daily) even if it was only for 3 weeks or less</li><li>have already had a course of corticosteroid tablets or injections in the last year</li><li>already had problems with your adrenal glands (adrenocortical insufficiency) before you started this treatment</li><li>take repeat doses in the evening.</li></ul><p>&nbsp;</p><p>You will need to come off Medrol slowly to avoid <strong>withdrawal symptoms</strong>. These symptoms may include itchy skin, fever, muscle and joint pains, runny nose, sticky eyes, loss of appetite, nausea, vomiting, headache, feeling tired, peeling skin and weight loss.</p><p>&nbsp;</p><p>If your symptoms seem to return or get worse as your dose of Medrol is reduced tell your doctor immediately.</p><p>&nbsp;</p><p><strong>Mental problems while taking Medrol</strong></p><p>&nbsp;</p><p>Mental health problems can happen while taking steroids like Medrol (see section 4).</p><ul><li>These illnesses can be serious.</li><li>Usually they start within a few days or weeks of starting the medicine.</li><li>They are more likely to happen at high doses.</li><li>Most of these problems go away if the dose is lowered or the medicine is stopped. However if the problems do happen they might need treatment.</li></ul><p>&nbsp;</p><p>Talk to a doctor if you (or someone using this medicine) shows any signs of mental problems. This is particularly important if you are depressed, or might be thinking about suicide. In a few cases mental problems have happened when doses are being lowered or stopped.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. Your doctor will have given you this medicine for a condition which if not treated properly could become serious.</p><p>&nbsp;</p><p>These side effects may occur with certain frequencies, which are defined as follows:</p><ul><li><em>common</em>: may affect up to 1 in 10 people.</li><li><em>rare</em>: may affect up to 1 in 1,000 people.</li><li><em>not known</em>: frequency cannot be estimated from the available data.</li></ul><p><strong>&nbsp;</strong></p><p><strong>In certain medical conditions medicines like Medrol (steroids) should not be stopped abruptly. If you suffer from any of the following symptoms, seek IMMEDIATE medical attention. Your doctor will then decide whether you should continue taking your medicine: </strong></p><p><strong>&nbsp;</strong></p><p><em>common</em></p><ul><li><strong>Burst or bleeding ulcers,</strong> symptoms of which are stomach pain (especially if it seems to spread to your back), bleeding from the back passage, black or bloodstained stools and/or vomiting blood.</li><li><strong>Infections. </strong>This medicine can hide or change the signs and symptoms of some infections, or reduce your resistance to the infection, so that they are hard to diagnose at an early stage. Symptoms might include a raised temperature and feeling unwell. Symptoms of a flare up of a previous TB infection could be coughing blood or pain in the chest. Medrol may also make you more likely to develop a severe infection.</li></ul><p><em>not known</em></p><ul><li><strong>Allergic reactions,</strong> such as skin rash, swelling of the face or wheezing and difficulty breathing. This type of side effect is rare, but can be serious.<strong> </strong></li><li><strong>Pancreatitis</strong>, stomach pain spreading to your back, possibly accompanied by vomiting, shock and loss of consciousness.</li><li><strong>Pulmonary embolus</strong> (blood clots in the lung), symptoms of include sudden sharp chest pain, breathlessness and coughing up blood.</li></ul><ul><li><strong>Raised pressure within the skull</strong> of children (pseudotumour cerebri) symptoms of which are headaches with vomiting, lack of energy and drowsiness. This side-effect usually occurs after treatment is stopped.</li><li><strong>Thrombophlebitis </strong>(blood clots or thrombosis in a leg vein), symptoms of which include painful swollen, red and tender veins.</li></ul><p>&nbsp;</p><p><strong>If you experience any of the following side effects, or notice any other unusual effects not mentioned in this leaflet, tell your doctor straight away:</strong></p><p><strong>&nbsp;</strong></p><p><strong>Blood, heart and circulation</strong></p><p><em>common</em></p><ul><li>High blood pressure, symptoms of which are headaches, or generally feeling unwell.</li></ul><p><em>not known</em></p><ul><li>Problems with the pumping of your heart (heart failure) symptoms of which are swollen ankles, difficulty in breathing and palpitations (awareness of heart beat) or irregular beating of the heart, irregular or very fast or slow pulse.</li><li>Increased numbers of white blood cells (leukocytosis).</li><li>Warmth and reddening of the skin (flushing).</li><li>Low blood pressure.</li></ul><p><em>&nbsp;</em></p><p><strong>Body water and salts</strong></p><p><em>common</em></p><ul><li>Swelling and high blood pressure, caused by increased levels of water and salt content.</li></ul><ul><li>Cramps and spasms, due to the loss of potassium from your body. In rare cases this can lead to congestive heart failure (when the heart cannot pump properly).</li></ul><p><em>not known</em></p><ul><li>Increased blood urea levels.</li></ul><p><strong>&nbsp;</strong></p><p><strong>Digestive system</strong></p><p><em>not known</em></p><ul><li>Nausea (feeling sick) or vomiting (being sick).</li><li>Ulcers, inflammation or thrush in the oesophagus (the tube that connects your mouth with your stomach), which can cause discomfort on swallowing.</li><li>Inflammation of the thin lining (peritoneum) around the gut and stomach.</li><li>Indigestion.</li><li>Bloated stomach.</li><li>Abdominal pain.</li><li>Diarrhoea.</li><li>Persistent hiccups, especially when high doses are taken.</li></ul><p>&nbsp;</p><p><strong>Eyes</strong></p><p><em>common</em></p><ul><li>Damage to the optic nerve or cataracts (indicated by failing eyesight).</li></ul><p><em>rare</em></p><ul><li>Blurred vision.</li></ul><p><em>not known</em></p><ul><li>Glaucoma (raised pressure within the eye, causing pain in the eyes and headaches).</li><li>Swollen optic nerve (papilloedema, indicated by sight disturbance).</li><li>Thinning of the clear part at the front of the eye (cornea) or of the white part of the eye (sclera).</li><li>Worsening of viral or fungal eye infections.</li><li>Protruding of the eyeballs (exophthalmos).</li><li>Blurred or distorted vision (due to a disease called chorioretinopathy).</li></ul><p><strong>&nbsp;</strong></p><p><strong>Hepatobiliary disorders </strong></p><p><em>not known</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase of liver enzymes.</p><p>&nbsp;</p><p><strong>Hormone and metabolic system</strong></p><p><em>common</em></p><ul><li>Slowing of normal growth in infants, children and adolescents which may be permanent.</li><li>Round or moon-shaped face (Cushingoid facies).</li></ul><p><em>not known</em></p><ul><li>Irregular or no periods in women.</li><li>Increased hair on the body and face in women (hirsutism).</li><li>Increased appetite and weight gain.</li><li>Abnormal blood level of lipids (e.g. cholesterol and/or fat).</li><li>Diabetes or worsening of existing diabetes.</li><li>Prolonged therapy can lead to lower levels of some hormones which in turn can cause low blood pressure and dizziness. This effect may persist for months.</li><li>The amount of certain chemicals (enzymes) called alanine transaminase, aspartate transaminase and alkaline phosphatase that help the body digest drugs and other substances in your body may be raised after treatment with a corticosteroid. The change is usually small and the enzyme levels return to normal after your medicine has cleared naturally from your system. You will not notice any symptoms if this happens, but it will show up if you have a blood test.</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accumulation of fat tissue on localised parts of the body, manifesting as different presentations for example back pain or weakness (due to epidural lipomatosis).</p><p>&nbsp;</p><p><strong>Immune system</strong></p><p><em>not known</em></p><ul><li>Increased susceptibility to infections which can hide or change normal reactions to skin tests, such as that for tuberculosis.</li></ul><p>&nbsp;</p><p><strong>Muscles and bones</strong></p><p><em>common</em></p><ul><li>Muscle weakness or wasting.</li></ul><p><em>not known</em></p><ul><li>Brittle bones (bones that break easily).</li><li>Broken bones or fractures.</li><li>Breakdown of bone due to poor circulation of blood, this causes pain in the hip.</li><li>Joint pain or joint problems.</li><li>Torn muscle tendons causing pain and/or swelling.</li><li>Muscle pain, cramps or spasms.</li></ul><p>&nbsp;</p><p><strong>Nervous system </strong></p><p>Steroids including methylprednisolone can cause serious mental health problems.</p><p>These are common in both adults and children. They can affect about 5 in every 100 people taking medicines like methylprednisolone.</p><ul><li>Feeling depressed, including thinking about suicide.</li><li>Feeling high (mania) or moods that go up and down.</li><li>Feeling anxious, having problems sleeping, difficulty in thinking or being confused and losing your memory.</li><li>Feeling, seeing or hearing things which do not exist. Having strange and frightening thoughts, changing how you act or having feelings of being alone.</li></ul><p><em>not known</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Irritability.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fits.</p><ul><li>Dizziness, a feeling of dizziness or &lsquo;spinning&rsquo;.</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache.</p><p>&nbsp;</p><p><strong>Skin</strong></p><p><em>common</em></p><ul><li>Acne.</li><li>Poor wound healing.</li><li>Thinning of skin.</li></ul><p><em>not known</em></p><ul><li>Stretch marks.</li><li>Bruising.</li><li>Sweating.</li><li>Itchy skin.</li><li>Rash or redness of skin.</li><li>Hives (red itchy swellings).</li><li>Dilation of small blood vessels on the surface of the skin (red spider veins).</li><li>Red, brown or purple, pin point, round spots.</li><li>Brown/purple/red raised patches on the skin or inside the mouth (Kaposi&rsquo;s sarcoma).</li></ul><p>&nbsp;</p><p><strong>Vascular disorders</strong></p><p><em>not known</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased clotting of the blood</p><p><strong>&nbsp;</strong></p><p><strong>Other side effects</strong></p><p><em>not known</em></p><ul><li>Feeling unwell.</li><li>Feeling tired.</li><li>Accumulation of fluid causing swelling in the body, especially the lower limbs.</li><li>Suppression of reactions to skin tests.</li></ul><p>&nbsp;</p><p>It is important if you are to have a blood test that you tell the doctor or nurse that you have been given treatment with Medrol.</p><p>&nbsp;</p><p><strong>If you experience any of the side effects listed above tell your doctor straight away</strong>.</p><p><strong>&nbsp;</strong></p><p><strong>Reporting of side effects</strong></p><p><strong>&nbsp;</strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. By reporting side effects, you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p><strong>To report side effects</strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia:</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>National Pharmacovigilance Center (NPC)</strong></p><ul><li>Call center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa/</li></ul></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other</strong><strong> GCC States</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date, which is stated on the carton and blister strip after &lsquo;EXP&rsquo;. The expiry date refers to the last day of that month.</p><p>Shelf life: 3 years.</p><p>Do not store above 30&deg;C.</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste.</p><p>Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is methylprednisolone.</p><p>Each Medrol Tablets 4 mg contain 4 mg methylprednisolone.</p><p>&nbsp;</p><p>The other ingredients are lactose, sucrose, maize starch and calcium stearate. &nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Medrol Tablets 4 mg are half oval, elliptical, white tablets debossed “Medrol 4” on one side and double scored on the other side. 
	It is available in bottles of 30 tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder</strong></p><p>Pfizer Italia S.r.l, Via Isonzo, 71-04100 Latina, Italy.</p><p>&nbsp;</p><p><strong>Manufacturer</strong></p><p>Pfizer Italia S.r.l., Localit&agrave; Marino del Tronto, 63100 Ascoli Piceno (AP), Italy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                November 2024.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي هذا الدواء على ميثيل بريدنيزولون، الذي ينتمي إلى مجموعة من الأدوية تُسمى الستيرويدات. الاسم الكامل لهذه المجموعة هو الستيرويدات القشرية. يتم إنتاج الستيرويدات القشرية بصورة طبيعية في جسمك وهي مهمة للعديد من وظائف الجسم.</p><p>&nbsp;</p><p dir="RTL">يُمكن لتعزيز جسمك بستيرويد قشري إضافي مثل ميدرول أن يساعد في حالة كان جسمك لا يستطيع إنتاج ما يكفي من الستيرويدات القشرية نتيجة لمعاناتك من مشكلات في غدتيك الكظريتين (مثل القصور الكظري).</p><p>&nbsp;</p><p dir="RTL">يمكن أن تساعد الستيرويدات القشرية أيضًا عقب الجراحات (مثل عمليات زراعة الأعضاء) أو الإصابات أو الحالات الأخرى المسببة للإجهاد. يتضمن ذلك الحالات الالتهابية أو حالات الحساسية التي تؤثر على:</p><p>&nbsp;</p><ul><li dir="RTL"><strong>الدماغ</strong> (مثل التهاب السحايا السلي)</li><li dir="RTL"><strong>الأمعاء</strong> (مثل مرض كرون والتهاب القولون التقرحي)</li><li dir="RTL"><strong>الدم أو الأوعية الدموية</strong> (مثل ابيضاض الدم)</li><li dir="RTL"><strong>العين </strong>(مثل التهاب العصب البصري أو التهاب العنبية أو التهاب القزحية)</li><li dir="RTL"><strong>المفاصل</strong> (مثل التهاب المفاصل الروماتويدي، الحمى الروماتيزمية)</li><li dir="RTL"><strong>الرئتين</strong> (مثل الربو، السل)</li><li dir="RTL"><strong>العضلات</strong> (مثل التهاب الجلد والعضل والتهاب العضلات)</li><li dir="RTL"><strong>الجلد</strong> (مثل الإكزيما)</li></ul><p>&nbsp;</p><p dir="RTL">يمكن أن يوصف ميدرول لعلاج حالات أخرى غير المدرجة أعلاه.</p><p dir="RTL">يجب عليك التحدث إلى طبيب إذا لم تكن متأكدًا من سبب وصف هذا الدواء لك أو إذا لم تشعر بتحسن أو إذا ساءت حالتك.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul><li dir="RTL"><table dir="rtl" border="1" cellspacing="0" cellpadding="0" align="right" style="width:100%"><tbody><tr><td style="vertical-align:bottom"><p dir="RTL"><strong>موانع استعمال ميدرول</strong></p><ul><li dir="RTL">إذا كنت تعتقد أنك سبق أن عانيت من <strong>تفاعل حساسية</strong> أو أي نوع آخر من التفاعلات بعد إعطائك ميدرول أو أي مكون آخر من مكونات هذا الدواء (مدرجة في القسم ٦). يمكن أن يسبب تفاعل الحساسية طفحًا جلديًا أو احمرارًا بالجلد أو تورم الوجه أو الشفتين أو ضيق التنفس.</li><li dir="RTL">إذا كنت تعاني من أي عدوى فطرية خطيرة مثل عدوى فطرية خطيرة برئتيك أو المريء (الأنبوب الذي يربط فمك بمعدتك) أو أي عدوى أخرى لا تتم معالجتها باستخدام دواء مضاد حيوي أو مضاد فيروسي.</li><li dir="RTL">إذا تلقيت مؤخرًا، أو سوف تتلقى قريبًا، أي <strong>تطعيم</strong>.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">إذا أصبت بطفح جلدي أو أي عرض آخر لعدوى، <strong>فأخبر طبيبك فورًا</strong>.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات عند استعمال ميدرول</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي قبل تناول هذا الدواء إذا كنت تعاني من أي من الحالات التالية.</p><p dir="RTL">قد يتوجب على طبيبك مراقبة علاجك عن كثب بصورة أكبر أو تعديل جرعتك أو إعطاؤك دواءً آخر.</p><p dir="RTL">&nbsp;</p><ul><li dir="RTL"><strong>الجديري المائي أو الحصبة أو الهربس النطاقي.</strong> إذا كنت تعتقد أنك خالطت شخصًا مصابًا بالجديري المائي أو الحصبة أو الهربس النطاقي ولم تكن قد أصبت من قبل بهذه الأمراض، أو إذا كنت غير متأكد مما إذا كنت قد أصبت بها من قبل أم لا.</li><li dir="RTL"><strong>تفشي الديدان</strong> (مثل الديدان الخيطية).</li><li dir="RTL"><strong>الاكتئاب الشديد</strong> أو <strong>الاكتئاب الهوسي</strong> (الاضطراب ثنائي القطب). يشمل هذا إصابتك بالاكتئاب سابقًا أثناء تناول أدوية ستيرويدية مثل ميدرول، أو امتلاكك لتاريخ عائلي من الإصابة بهذه الأمراض.</li></ul><ul><li dir="RTL"><strong>داء السكري</strong> (أو في حالة وجود تاريخ عائلي من الإصابة بداء السكري).</li><li dir="RTL"><strong>النوبات</strong>.</li><li dir="RTL"><strong>الزرق</strong> (زيادة الضغط داخل العين) أو في حالة وجود تاريخ عائلي من الإصابة بالزرق، أو إذا كنت تعاني من <strong>إعتام عدسة العين</strong>.</li><li dir="RTL">اتصل بطبيبك إذا أصبت <strong>بتغيم الرؤية أو بأي اضطرابات بصرية أخرى</strong>.</li><li dir="RTL">عدوى <strong>فيروسية</strong> (مثل الهربس) أو <strong>فطرية</strong> بالعين.</li><li dir="RTL">إذا عانيت مؤخرًا من <strong>أزمة قلبية</strong>.</li><li dir="RTL"><strong>مشكلات القلب</strong>، بما في ذلك فشل القلب.</li><li dir="RTL"><strong>ارتفاع ضغط الدم</strong> (ضغط الدم المرتفع).</li><li dir="RTL"><strong>قصور الدرقية</strong> (غدة درقية منخفضة النشاط).</li><li dir="RTL"><strong>فرط الدرقية</strong> (غدة درقية مفرطة النشاط)<strong>.</strong></li><li dir="RTL"><strong>التهاب البنكرياس</strong> (التهاب البنكرياس الذي يسبب ألمًا شديدًا في البطن والظهر).</li><li dir="RTL"><strong>التهاب الصفاق</strong> (التهاب البطانة الرقيقة (الصفاق) التي تغلف الأمعاء والمعدة).</li><li dir="RTL">مرض <strong>بالكليتين</strong> أو <strong>الكبد</strong>.</li><li dir="RTL"><strong>تصلب الجلد</strong> (يُعرف أيضًا باسم التصلب الجهازي، وهو اضطراب مناعي)، نظرًا لأنه قد يزيد خطر التعرض لإحدى المضاعفات الخطيرة تسمى أزمة الكلى الناتجة عن تصلب الجلد. تتضمن علامات أزمة الكلى الناتجة عن تصلب الجلد زيادة ضغط الدم وانخفاض إنتاج البول.</li><li dir="RTL"><strong>ساركومة كابوزي</strong> (نوع من سرطان الجلد).</li><li dir="RTL"><strong>مشكلات العضلات</strong> (ألم أو ضعف) التي حدثت في الماضي أثناء تناول أدوية ستيرويدية مثل ميدرول.</li><li dir="RTL"><strong>الوهن العضلي الوبيل</strong> (حالة تسبب تعب العضلات وضعفها).</li><li dir="RTL"><strong>هشاشة العظام</strong> (تكون العظام ضعيفة وسهلة الانكسار).</li><li dir="RTL"><strong>الفيوكروموسيتوما</strong> (ورم نادر يصيب نسيج الغدة الكظرية. تقع الغدتان الكظريتان فوق الكليتين).</li><li dir="RTL"><strong>خراج الجلد</strong>.</li><li dir="RTL"><strong>قرحة المعدة</strong> أو مشكلات أخرى خطيرة بالمعدة أو الأمعاء.</li><li dir="RTL"><strong>التهاب الوريد الخثاري</strong> - مشكلات بالأوردة نتيجة تكون خثرات (جلطات في الأوردة) وتؤدي إلى التهاب وريدي (احمرار الأوردة وتورمها وتوجعها).</li><li dir="RTL"><strong>السل</strong> (TB) أو إذا كنت قد عانيت من السل في الماضي.</li><li dir="RTL"><strong>مرض كوشينغ</strong> (حالة تنتج عن فرط هرمون الكورتيزول في جسمك).</li><li dir="RTL"><strong>إصابة في الدماغ</strong> نتيجة للصدمات (الإصابة).</li><li dir="RTL"><strong>الإجهاد</strong> غير المألوف.</li></ul><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">اتصل بطبيبك على الفور إذا أصبت بضعف العضلات وألم العضلات وتشنجها وتيبسها خلال فترة استخدام ميثيل بريدنيزولون. فقد تكون هذه أعراض حالة تسمى الشلل الانسمامي الدرقي الدوري، وهي حالة قد تحدث لدى المرضى الذين تكون غدتهم الدرقية مفرطة النشاط (فرط الدرقية) ممن يخضعون للعلاج بميثيل بريدنيزولون. قد تحتاج إلى علاج إضافي لتخفيف هذه الحالة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن أن تحدث متلازمة انحلال الورم (TLS) بعد علاج السرطان سريع النمو، مثل سرطانات الدم أو الأورام الصلبة. وتتضمن أعراض متلازمة انحلال الورم تشنج العضلات، وضعف العضلات، والارتباك، وعدم انتظام ضربات القلب، وفقدان الرؤية أو اضطرابات الرؤية، وضيق التنفس. سيراقبك طبيبك عن كثب، خاصة إذا كنت معرضًا لخطر كبير للإصابة بمتلازمة انحلال الورم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&zwnj;التداخلات الدوائية مع أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى، (بما فيها تلك الأدوية التي حصلت عليها بدون وصفة طبية). فقد يكون هذا ضارًا أو يؤثر في الطريقة التي يعمل بها ميدرول أو الدواء الآخر:</p><p dir="RTL">&nbsp;</p><ul><li dir="RTL"><strong>أسيتازولاميد</strong> - يستخدم لعلاج الزرق والصرع.</li><li dir="RTL"><strong>أمينوجلوتيثيميد</strong> أو <strong>سيكلوفوسفاميد</strong> - يستخدمان لعلاج السرطان.</li><li dir="RTL"><strong>مضادات التجلط</strong> - تستخدم &quot;لتسييل&quot; الدم مثل أسينوكومارول وفينينديون ووارفارين.</li><li dir="RTL"><strong>مضادات الكولينيستيراز</strong> - تستخدم لعلاج الوهن العضلي الوبيل (حالة تصيب العضلات) مثل ديستيجمين ونيوستيجمين.</li><li dir="RTL"><strong>مضادات البكتيريا</strong> (مثل أيزونيازيد وإريثرومايسين وكلاريثرومايسين وترولياندومايسين).</li><li dir="RTL"><strong>الأدوية المضادة للسكري</strong> &ndash; أدوية تستخدم لعلاج سكر الدم المرتفع.</li><li dir="RTL"><strong>أبريبيتانت</strong> أو <strong>فوسابريبيتانت</strong> - يستخدمان لمنع الغثيان والقيء.</li></ul><ul><li dir="RTL"><strong>الأسبرين</strong> ومضادات الالتهاب غير الستيرويدية (يطلق عليها اختصارًا <strong>NSAIDs</strong>) مثل إيبوبروفين المستخدم لعلاج الألم خفيف الشدة إلى متوسط الشدة.</li><li dir="RTL"><strong>الباربيتيورات</strong> <strong>وكرباميزيبين</strong> <strong>وفينيتوين</strong> و<strong> بريميدون</strong> - تستخدم لعلاج الصرع.</li><li dir="RTL"><strong>كربينوكسولون</strong> <strong>وسيميتيدين</strong> - تستخدم لحرقة فم المعدة وعسر الهضم الحمضي.</li></ul><ul><li dir="RTL"><strong>سيكلوسبورين</strong> - يستخدم لعلاج الحالات مثل التهاب المفاصل الروماتويدي الشديد أو الصدفية الحادة أو عقب زراعة عضو أو نخاع عظمي.</li><li dir="RTL"><strong>ديجوكسين</strong> - يستخدم لعلاج فشل القلب و/أو دقات القلب غير المنتظمة.</li><li dir="RTL"><strong>ديلتيازيم</strong> أو <strong>ميبيفراديل</strong> - يستخدم لعلاج مشكلات القلب أو ضغط الدم المرتفع.</li><li dir="RTL"><strong>إيثينيل إيستريديول</strong> <strong>ونوريثيستيرون</strong> - مانع حمل فموي.</li><li dir="RTL"><strong>مضادات الفيروسات</strong> (مثل ريتونافير، إندينافير) و<strong>معززات الحرائك الدوائية </strong>(مثل كوبيسيستات) تستخدم لعلاج عدوى فيروس نقص المناعة البشرية (HIV).</li><li dir="RTL"><strong>كيتوكونازول</strong> أو <strong>إيتراكونازول</strong> - يستخدم لعلاج حالات العدوى الفطرية.</li><li dir="RTL"><strong>بانكورونيوم</strong> أو <strong>فيركورونيوم</strong> - أو الأدوية الأخرى التي يطلق عليها عوامل الحصر العصبية العضلية التي تستخدم في بعض الإجراءات الجراحية.</li><li dir="RTL"><strong>العوامل المستنفدة للبوتاسيوم</strong> &ndash; مثل <strong>مدرات البول</strong> (يطلق عليها أحيانًا أقراص الماء)، أو <strong>أمفوتيريسين ب</strong>، أو <strong>الزانثينات</strong> أو <strong>ناهضات مستقبلات بيتا </strong><strong>۲</strong> (مثل الأدوية المستخدمة لعلاج الربو).</li><li dir="RTL"><strong>ريفامبيسين</strong> <strong>وريفابوتين</strong> - مضادات حيوية تستخدم لعلاج السل (TB).</li><li dir="RTL"><strong>تاكروليموس</strong> - يستخدم عقب زراعة عضو لمنع رفض الجسم للعضو.</li><li dir="RTL"><strong>اللقاحات</strong> - أخبر طبيبك أو الممرضة إذا كنت قد تلقيت مؤخرًا، أو على وشك تلقي، أي تطعيم. <strong>يجب ألا</strong> يتم تطعيمك بلقاحات &quot;حية&quot; أثناء استخدام هذا الدواء. قد تكون اللقاحات الأخرى أقل فعالية.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا كنت تتناول أدوية طويلة الأمد</strong></p><p dir="RTL">إذا كان يتم علاجك من داء السكري أو ضغط الدم المرتفع أو احتباس الماء (التورم)، فأخبر طبيبك حيث إنه قد يحتاج إلى تعديل جرعة الأدوية المستخدمة لعلاج هذه الحالات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>قبل أن تخضع لأي عملية،</strong> أخبر طبيبك أو طبيب الأسنان أو أخصائي التخدير أنك تتناول ميدرول.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا كنت تحتاج إلى إجراء اختبار بواسطة طبيبك أو في مستشفى،</strong> من المهم أن تخبر الطبيب أو الممرضة أنك تتناول ميدرول. قد يؤثر هذا الدواء على نتائج بعض الاختبارات.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">إذا كنتِ حاملًا أو تعتقدين أنك ربما تكونين حاملًا أو تخططين للحمل، فاستشيري طبيبك أو الصيدلي قبل تناول هذا الدواء نظرًا لأنه قد يبطئ من معدل نمو الجنين. هناك خطر بانخفاض وزن الطفل عند الولادة؛ يمكن خفض الخطر بتناول أقل جرعة فعالة من الستيرويدات القشرية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لوحظ حدوث حالات إعتام عدسة العين في الأطفال الرضع الذين خضعت أمهاتهم للعلاج طويل الأمد بالستيرويدات القشرية أثناء الحمل.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL">إذا كنت تُرضعين رضاعة طبيعية، فاستشيري طبيبك أو الصيدلي نظرًا لأنه قد تنتقل كميات صغيرة من أدوية الستيرويدات القشرية إلى لبن الثدي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثير ميدرول على القيادة واستخدام الآلات</strong></p><p dir="RTL">من المحتمل حدوث بعض الأعراض غير المرغوب فيها مثل الدوار والدوخة واضطرابات الرؤية والإرهاق بعد العلاج بالستيرويدات القشرية. إذا أصابك أي منها، فتجنب القيادة أو تشغيل الآلات.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>معلومات هامة حول بعض مكونات ميدرول</strong></p><p dir="RTL"><strong>يحتوي ميدرول على اللاكتوز والسكروز</strong></p><p dir="RTL">إذا أخبرك طبيبك أنك لا تستطيع تحمل بعض السكريات، فأخبره قبل تناول هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي هذا الدواء على اللاكتوز الذي يتم إنتاجه من حليب البقر. ينبغي توخي الحذر مع المرضى الذين يعانون فرط التحسس المعروفة أو المشتبه بها تجاه حليب البقر أو مكوناته أو منتجات الألبان الأخرى لأن الدواء قد يحتوي على كميات ضئيلة من مكونات الحليب. إذا كنت تعاني حساسية تجاه حليب البقر، فتحدث إلى طبيبك أو الصيدلي أولًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table></li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احرص دومًا على تناول هذا الدواء تمامًا كما أخبرك طبيبك أو الصيدلي. استشر طبيبك أو الصيدلي إذا لم تكن متأكدًا مما عليك فعله.</p><p>&nbsp;</p><p dir="RTL"><strong>بطاقات العلاج بالستيرويدات</strong></p><p dir="RTL"><strong>تذكر دائمًا أنه يجب أن تحمل بطاقة العلاج بالستيرويدات. تأكد من أن طبيبك أو الصيدلي قد ملأ بيانات دوائك، بما في ذلك الجرعة والمدة التي سوف تحتاج خلالها للعلاج بالستيرويدات. </strong></p><p>&nbsp;</p><p dir="RTL">ينبغي عليك أن تُظهر بطاقة العلاج بالستيرويدات الخاصة بك <em>لأي شخص </em>يقوم بمعالجتك (كطبيب أو ممرضة أو طبيب أسنان) أثناء تناولك ميدرول ولمدة ۳ أشهر بعد توقفك عن تناول الأقراص.</p><p>&nbsp;</p><p dir="RTL">إذا دخلت المستشفى لأي سبب، فأخبر طبيبك أو الممرضة دائمًا بأنك تتناول ميدرول. يمكنك أيضًا ارتداء قلادة أو سوار للتنبيه الطبي (medic-alert) لإحاطة طاقم العمل الطبي علمًا بأنك تتناول دواءً ستيرويديًا إذا تعرضت لحادث أو فقدت الوعي.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>البالغون</strong></p><p dir="RTL">تتراوح الجرعة اليومية العادية بين ٤ ملجم و۳٦۰ ملجم يوميًا، حسب حالتك ومدى شدتها. سوف يصف لك طبيبك أقل جرعة ممكنة.</p><p dir="RTL">قد يطلب منك طبيبك تناول جرعتك اليومية دفعة واحدة، أو تقسيم جرعتك اليومية على مدار اليوم، أو تناولها كل يومين في الساعة ۸.۰۰ صباحًا.</p><p>&nbsp;</p><p dir="RTL">ابتلع الأقراص <strong>كاملة</strong> مع شرب كوب من الماء.</p><p dir="RTL">لا تأكل فاكهة الجريب فروت أو تشرب عصير جريب فروت أثناء تناولك ميدرول.</p><p>&nbsp;</p><p dir="RTL">إذا كنت تتناول ميدرول لأن جسمك لا يمكنه إنتاج الستيرويدات القشرية بنفسه، فقد يرغب طبيبك كذلك في أن تتناول نوعًا ثانيًا من الستيرويدات للمساعدة في تحقيق توازن الأملاح في جسمك.</p><p>&nbsp;</p><p dir="RTL">قد يصف طبيبك جرعة أعلى عند بدء علاجك للسيطرة على حالتك.</p><p>&nbsp;</p><p dir="RTL">عندما يصبح طبيبك راضيًا لأن حالتك قد تحسنت، سوف يتم خفض جرعتك تدريجيًا. سوف يتم خفض الجرعة عادة بمعدل لا يزيد عن ۲ ملجم كل ٧ إلى ۱۰ أيام.</p><p>&nbsp;</p><p dir="RTL"><strong>المسنون:</strong></p><p dir="RTL">قد يرغب طبيبك في رؤيتك بمعدل أكثر تكرارًا وانتظامًا للاطمئنان على مدى تحسن حالتك مع تناول الأقراص.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>الأطفال والمراهقون:</strong></p><p dir="RTL">يمكن للستيرويدات القشرية أن تؤثر على النمو في الأطفال، لذا سيصف طبيبك أقل جرعة تكون فعالة لطفلك. قد يطلب منك طبيبك إعطاء طفلك هذا الدواء كل يومين.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>&zwnj;الجرعة الزائدة من ميدرول</strong></p><p dir="RTL">من المهم ألا تتناول أقراصًا أكثر مما طُلب منك تناوله. إذا تناولت دون قصد كمية من الأقراص أكبر مما ينبغي، فالجأ للرعاية الطبية فورًا.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>&zwnj;نسيان تناول جرعة ميدرول</strong></p><p dir="RTL">انتظر وتناول الجرعة التالية في الوقت المعتاد. لا تتناول جرعة لتعوِّض الجرعة التي نسيتها ولكن أخبِر طبيبك أو الصيدلي بما حدث.</p><p>&nbsp;</p><p dir="RTL"><strong>&zwnj;التوقف عن تناول ميدرول</strong></p><p dir="RTL">سوف يقرِّر طبيبك الوقت المناسب لإيقاف جرعتك.</p><p>&nbsp;</p><p dir="RTL"><strong>يجب ألا تتوقف عن تناول ميدرول فجأة،</strong> خاصة إذا كنت قد:</p><ul><li dir="RTL">تناولت أكثر من ٦ ملجم من ميدرول يوميًا لأكثر من ۳ أسابيع</li><li dir="RTL">تم إعطاؤك جرعات عالية من ميدرول (أكثر من ۳۲ ملجم يوميًا) حتى ولو لمدة ۳ أسابيع أو أقل فقط</li><li dir="RTL">أتممت بالفعل دورة علاجية بأقراص أو حقن الستيرويدات القشرية في السنة الأخيرة</li><li dir="RTL">عانيت بالفعل من مشكلات بغدتيك الكظريتين (قصور القشرة الكظرية) قبل أن تبدأ هذا العلاج</li><li dir="RTL">أخذت جرعات متكررة في المساء.</li></ul><p>&nbsp;</p><p dir="RTL">سوف تحتاج إلى إيقاف ميدرول ببطء لتجنب <strong>أعراض الانسحاب</strong>. قد تشمل هذه الأعراض حكة الجلد والحمى وآلام العضلات والمفاصل وارتشاح الأنف ووجود إفرازات دبقة (لزجة) في العينين وفقدان الشهية والغثيان والقيء والصداع والشعور بالتعب وتقشر الجلد وفقدان الوزن.</p><p>&nbsp;</p><p dir="RTL">إذا كان يبدو أن أعراضك تعود أو تسوء مع خفض جرعتك من ميدرول، فأخبر طبيبك فورًا.</p><p>&nbsp;</p><p dir="RTL"><strong>المشكلات العقلية أثناء تناول ميدرول</strong></p><p dir="RTL">يمكن أن تحدث مشكلات في الصحة العقلية أثناء تناول الستيرويدات مثل ميدرول (انظر القسم ٤).</p><ul><li dir="RTL">يمكن أن تكون هذه الأمراض خطيرة،</li><li dir="RTL">وتظهر عادةً خلال بضعة أيام أو أسابيع من بداية العلاج بالدواء.</li><li dir="RTL">ومن المرجّح أكثر أن تظهر مع الجرعات العالية.</li><li dir="RTL">تختفي معظم هذه المشكلات إذا تم خفض الجرعة أو إيقاف الدواء. لكن إذا حدثت هذه المشكلات بالفعل، فقد تحتاج للعلاج.</li></ul><p>&nbsp;</p><p dir="RTL">تحدث إلى طبيب إذا ظهرت عليك (أو على أي شخص يستخدم هذا الدواء) أي علامات لوجود مشكلات عقلية. يكون ذلك مهمًا على وجه الخصوص إذا كنتَ مكتئبًا أو ربما تفكر في الانتحار. في حالات قليلة، حدثت مشكلات عقلية عند خفض أو إيقاف الجرعات.</p><p>&nbsp;</p><p dir="RTL">إذا كان لديك المزيد من الأسئلة بشأن استخدام هذا الدواء، فاسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <table dir="rtl" border="1" cellspacing="0" cellpadding="0" align="right" style="width:100%"><tbody><tr><td style="vertical-align:bottom"><p dir="RTL">كما هو الحال بالنسبة لجميع الأدوية، قد يسبب هذا الدواء أعراضًا جانبية، غير أنها لا تصيب الجميع. سيكون طبيبك قد وصف لك هذا الدواء لعلاج حالة قد تصبح خطيرة إذا لم يتم علاجها كما ينبغي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">من الممكن أن تحدث هذه الأعراض الجانبية بمعدلات تكرار معينة تم تعريفها على النحو التالي:</p><ul><li dir="RTL"><em>شائعة:</em> قد تصيب ما يصل إلى شخص واحد من بين كل ۱۰ أشخاص.</li><li dir="RTL"><em>نادرة:</em> قد تصيب ما يصل إلى شخص واحد من بين كل ۱۰۰۰ شخص.</li><li dir="RTL"><em>غير معروفة:</em> لا يمكن تقدير معدل التكرار من البيانات المتاحة.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حالات طبية معينة، ينبغي عدم إيقاف الأدوية مثل ميدرول (الستيرويدات) بشكل مفاجئ. إذا كنت تعاني من أي من الأعراض التالية، فالجأ للرعاية الطبية فورًا. سوف يقرر طبيبك حينئذ إذا ما كان ينبغي أن تستمر في تناول دوائك أم لا: </strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>شائعة</em></p><ul><li dir="RTL"><strong>القرح الانفجارية أو النازفة،</strong> والتي تكون أعراضها ألم بالمعدة (خاصة إذا كان يبدو أنه يمتد لظهرك)، و/أو نزيف من الشرج، و/أو براز أسود أو ملوّث بالدم و/أو تقيؤ الدم.</li><li dir="RTL"><strong>العدوى.</strong> يمكن أن يخفي هذا الدواء أو يغيّر علامات وأعراض بعض صور العدوى، أو يقلِّل مقاومتك للعدوى، بشكل يجعل من الصعب تشخيصها في مرحلة مبكِّرة. قد تشمل الأعراض ارتفاع درجة الحرارة والشعور بالتوعك. يمكن أن تظهر أعراض نوبة احتدام عدوى سل سابقة على هيئة سعال دموي أو آلام بالصدر. يمكن أن يجعلك ميدرول أيضًا أكثر عرضة للإصابة بعدوى شديدة.</li></ul><p dir="RTL"><em>غير معروفة</em></p><ul><li dir="RTL"><strong>تفاعلات الحساسية،</strong> مثل الطفح الجلدي أو تورم الوجه أو الأزيز وصعوبة التنفس. هذا النوع من الأعراض الجانبية نادر، ولكن يمكن أن يكون خطيرًا.</li><li dir="RTL"><strong>التهاب البنكرياس،</strong> ألم بالمعدة يمتد إلى ظهرك، من المحتمل أن يكون مصحوبًا بالقيء والصدمة وفقدان الوعي.</li><li dir="RTL"><strong>الانسداد الرئوي</strong> (جلطات دموية في الرئة)، وتتضمن أعراضها ألم حاد مفاجئ بالصدر وضيق التنفس والسعال الدموي.</li></ul><ul><li dir="RTL"><strong>ارتفاع الضغط داخل جماجم الأطفال</strong> (ورم دماغي كاذب) وأعراضه هي الصداع مع القيء ونقص الطاقة والشعور بالنعاس. يحدث هذا الأثر الجانبي عادةً بعد إيقاف العلاج.</li><li dir="RTL"><strong>التهاب الوريد الخثاري</strong> (جلطات دموية أو خثار في وريد بالساق)، وتتضمن أعراضه ألم الأوردة وتورمها واحمرارها وتوجعها.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا أُصِبت بأيٍ من </strong><strong>الأعراض</strong><strong> الجانبية التالية أو لاحظت أي تأثيرات أخرى غير معتادة وغير مذكورة في هذه النشرة، فأخبر طبيبك فورًا:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الدم والقلب والدورة الدموية</strong></p><p dir="RTL"><em>شائعة</em></p><ul><li dir="RTL">ضغط الدم المرتفع، وأعراضه هي الصداع، أو الشعور بالتوعك بوجه عام.</li></ul><p dir="RTL"><em>غير معروفة</em></p><ul><li dir="RTL">مشكلات في ضخ قلبك (فشل القلب) وأعراضه هي تورم الكاحلين أو صعوبة في التنفس وخفقان (الإحساس بقوة ضربات القلب) أو ضربات قلب غير منتظمة، والنبض غير المنتظم أو السريع أو البطيء للغاية.</li><li dir="RTL">زيادة أعداد خلايا الدم البيضاء (كثرة الكريات البيضاء).</li><li dir="RTL">دفء الجلد أو احمراره (الاحمرار).</li><li dir="RTL">ضغط الدم المنخفض.</li></ul><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><strong>الماء والأملاح بالجسم</strong></p><p dir="RTL"><em>شائعة</em></p><ul><li dir="RTL">التورم وضغط الدم المرتفع، الناتجان بسبب المستويات الزائدة من الماء والمحتوى الملحي.</li></ul><ul><li dir="RTL">شد وتقلصات نتيجة فقد البوتاسيوم من جسمك. في حالات نادرة، يمكن لذلك أن يؤدي إلى فشل القلب الاحتقاني (عندما لا يستطيع القلب الضخ بشكل سليم).</li></ul><p dir="RTL"><em>غير معروفة:</em></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستويات اليوريا في الدم.</p><p dir="RTL"><strong>الجهاز الهضمي</strong></p><p dir="RTL"><em>غير معروفة</em></p><ul><li dir="RTL">الغثيان (الشعور بالرغبة في التقيؤ) أو القيء (التقيؤ بالفعل).</li><li dir="RTL">وجود قرح، أو التهاب أو قلاع بالمريء (الأنبوب الذي يربط بين فمك ومعدتك)، مما قد يسبب شعورًا بعدم الراحة عند البلع.</li><li dir="RTL">التهاب البطانة الرقيقة (الصفاق) التي تغلف الأمعاء والمعدة.</li><li dir="RTL">عسر الهضم.</li><li dir="RTL">انتفاخ المعدة.</li><li dir="RTL">ألم البطن.</li><li dir="RTL">الإسهال.</li><li dir="RTL">الزغطة المستديمة، خاصة عندما يتم تناول جرعات عالية.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>العينان</strong></p><p dir="RTL"><em>شائعة</em></p><ul><li dir="RTL">التلف بالعصب البصري أو إعتام عدسة العين (من مؤشرات الإصابة به المعاناة من ضعف في الإبصار).</li></ul><p dir="RTL"><em>نادرة</em></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيم الرؤية</p><p dir="RTL"><em>غير معروفة</em></p><ul><li dir="RTL">الزرق (ارتفاع الضغط داخل العين، مما يسبب ألمًا في العينين وحالات صداع).</li><li dir="RTL">تورم العصب البصري (وذمة الحليمة ومن مؤشراتها المعاناة من اضطراب بالإبصار).</li><li dir="RTL">ترقق الجزء الشفاف في مقدمة العين (القرنية) أو الجزء الأبيض من العين (الصلبة).</li><li dir="RTL">تفاقم العدوى الفيروسية أو الفطرية بالعين.</li><li dir="RTL">بروز مقلتي العينين (الجحوظ).</li><li dir="RTL">تغيُّم أو تشوه الرؤية (نتيجة مرض يُطلق عليه اعتلال المشيمية والشبكية).</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاضطرابات الكبدية الصفراوية </strong></p><p dir="RTL"><em>غير معروفة</em></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة إنزيمات الكبد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجهاز الهرموني والأيضي</strong></p><p dir="RTL"><em>شائعة</em></p><ul><li dir="RTL">إبطاء النمو الطبيعي في الرضّع والأطفال والمراهقين وقد يكون ذلك أثرًا دائمًا.</li><li dir="RTL">وجه بالغ الاستدارة أو يشبه القمر في استدارته (وجوه كوشينغ).</li></ul><p dir="RTL"><em>غير معروفة</em></p><ul><li dir="RTL">عدم انتظام الدورات الشهرية أو توقفها لدى السيدات.</li><li dir="RTL">زيادة الشعر على الجسم والوجه لدى السيدات (غزارة في نمو الشعر).</li><li dir="RTL">زيادة الشهية وزيادة الوزن.</li><li dir="RTL">مستويات غير طبيعية للدهون في الدم (مثل الكوليسترول و/أو الشحوم).</li><li dir="RTL">داء السكري أو تفاقم السكري الموجود بالفعل.</li><li dir="RTL">يُمكن للعلاج المطوّل أن يؤدي إلى انخفاض مستويات بعض الهرمونات، الأمر الذي قد يسبب بدوره ضغط الدم المنخفض والدوار. قد يستمر هذا الأثر لشهور.</li><li dir="RTL">قد ترتفع كمية مواد كيميائية معيّنة (إنزيمات) يطلق عليها ناقلة أمين الألانين، وناقلة أمين الأسبارتات والفوسفاتاز القلوي التي تساعد الجسم على هضم العقاقير والمواد الأخرى في جسمك، وذلك بعد العلاج بأحد الستيرويدات القشرية. يكون التغير عادةً بسيطًا وتعود مستويات الإنزيمات إلى مستواها الطبيعي بعد أن يتم التخلص من دوائك بصورة طبيعية من جسمك. لن تلاحظ أي أعراض إذا حدث ذلك، ولكنه سيظهر إذا خضعت لفحص الدم.</li></ul><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تراكم الأنسجة الدهنية على أجزاء موضعية من الجسم، ويظهر ذلك في صور مختلفة مثل ألم أو ضعف في الظهر (نتيجة الورم الشحمي فوق الجافية).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجهاز المناعي</strong></p><p dir="RTL"><em>غير معروفة</em></p><ul><li dir="RTL">زيادة قابلية الإصابة بالعدوى، الأمر الذي قد يخفي أو يغيّر التفاعلات الطبيعية لاختبارات الجلد، مثل تلك الخاصة بالسل.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>العضلات والعظام</strong></p><p dir="RTL"><em>شائعة</em></p><ul><li dir="RTL">ضعف أو ضمور العضلات.</li></ul><p dir="RTL"><em>غير معروفة</em></p><ul><li dir="RTL">هشاشة العظام (عظام تنكسر بسهولة).</li><li dir="RTL">كسور العظام.</li><li dir="RTL">تحلل العظام نتيجة ضعف الدورة الدموية، مما يسبب ألمًا في الورك.</li><li dir="RTL">آلام أو مشكلات بالمفاصل.</li><li dir="RTL">تمزق أوتار العضلات مما يسبب الألم و/أو التورم.</li><li dir="RTL">آلام أو شد أو تقلصات بالعضلات.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجهاز العصبي </strong></p><p dir="RTL">قد تسبب الستيرويدات بما فيها ميثيل بريدنيزولون مشكلات خطيرة بالصحة العقلية.</p><p dir="RTL">وهي شائعة في كلٍ من البالغين والأطفال، وقد تصيب حوالي ٥ أشخاص من كل ۱۰۰ شخص يتناولون الأدوية المشابهة لميثيل بريدنيزولون.</p><ul><li dir="RTL">الشعور بالاكتئاب، بما في ذلك التفكير في الانتحار.</li><li dir="RTL">الشعور بالانتشاء (الهوس) أو التقلبات المزاجية.</li><li dir="RTL">الشعور بالقلق، والمعاناة من مشكلات بالنوم، والصعوبة في التفكير أو الشعور بالارتباك وفقدان الذاكرة.</li><li dir="RTL">الشعور بأشياء غير موجودة أو رؤيتها أو سماعها. المعاناة من أفكار غريبة ومخيفة، أو تغير في تصرفاتك أو الشعور بالوحدة.</li></ul><p dir="RTL"><em>غير معروفة</em></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الانفعالية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النوبات.</p><ul><li dir="RTL">الدوار، الشعور بالدوار أو &lsquo;الدوخة&lsquo;.</li></ul><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجلد</strong></p><p dir="RTL"><em>شائعة</em></p><ul><li dir="RTL">حب الشباب.</li><li dir="RTL">ضعف التئام الجروح.</li><li dir="RTL">ترقق الجلد.</li></ul><p dir="RTL"><em>غير معروفة</em></p><ul><li dir="RTL">علامات التمدد.</li><li dir="RTL">التكدم.</li><li dir="RTL">العرق.</li><li dir="RTL">حكة الجلد.</li><li dir="RTL">طفح جلدي أو احمرار الجلد.</li><li dir="RTL">شرى (تورمات حمراء بها حكة).</li><li dir="RTL">تمدد الأوعية الدموية الصغيرة على سطح الجلد (أوردة عنكبوتية حمراء).</li><li dir="RTL">بقع دبوسية مستديرة حمراء أو بنية أو أرجوانية.</li><li dir="RTL">بقع بنية/أرجوانية/حمراء مرتفعة على الجلد أو داخل الفم (ساركومة كابوزي).</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاضطرابات الوعائية</strong></p><p dir="RTL"><em>غير معروفة</em></p><p dir="RTL"><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>زيادة تجلط الدم</em></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأعراض الجانبية الأخرى</strong></p><p dir="RTL"><em>غير معروفة</em></p><ul><li dir="RTL">الشعور بالتوعك.</li><li dir="RTL">الشعور بالتعب.</li><li dir="RTL">تراكم السوائل مما يسبب تورم الجسم، خاصة في الأطراف السفلية.</li><li dir="RTL">تثبيط التفاعلات لاختبارات الجلد.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">من المهم إذا كنت ستخضع لفحص دم أن تخبر الطبيب أو الممرضة أنه قد تمت معالجة حالتك باستخدام ميدرول.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا أُصِبت بأيِ من الأعراض الجانبية المدرجة أعلاه، فأخبِر طبيبك فورًا.</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا أصبت بأي أعراض جانبية، فتحدث إلى طبيبك أو الصيدلي. يتضمن ذلك أي أعراض جانبية محتملة غير مدرجة في هذه النشرة. بالإبلاغ عن الأعراض الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>-&nbsp; </strong><strong>&nbsp;المركز الوطني للتيقظ الدوائي</strong><strong>:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مركز الاتصال الموحد: ١٩٩٩٩</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الالكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الالكتروني: https://ade.sfda.gov.sa</p></td></tr></tbody></table><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول الخليج الأخرى</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة.</em></p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">احفظ هذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المُدون على العبوة الكرتونية وشرائط الدواء بعد &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL">صلاحية المستحضر:۳ سنوات<br />لا يخزّن في درجة حرارة أعلى من ۳۰&deg; مئوية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتخلص من أي أدوية عبر مياه الصرف أو في المخلفات المنزلية.</p><p dir="RTL">اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه الإجراءات على حماية البيئة.</p></td></tr></tbody></table><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">المادة الفعّالة هي ميثيل بريدنيزولون.</p><p dir="RTL">يحتوي كل قرص من أقراص ميدرول ٤ ملجم على ٤ ملجم من ميثيل بريدنيزولون.</p><p dir="RTL">&nbsp;</p><p dir="RTL">المكونات الأخرى هي لاكتوز وسكروز ونشا الذرة وستيارات الكالسيوم.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">أقراص ميدرول ٤ ملجم بيضاء اللون شبه بيضاوية ذات شكل إهليلجي، مكتوب على أحد الوجهين &quot;Medrol 4&quot;، وعلى الوجه الآخر تحزيز مضاعف.</p><p dir="RTL">وهي تتوافر في عبوات تحتوي على ۳۰ قرصًا.</p></td></tr></tbody></table><p style="text-align:right">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>مالك رخصة التسويق</strong></p><p dir="RTL">Pfizer Italia S.r.l, Via Isonzo 71-04100 Latina, Italy</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>المصنع</strong></p><p dir="RTL">Pfizer Italia S.r.l., Localit&agrave; Marino del Tronto, 63100 Ascoli Piceno (AP), Italy، إيطاليا.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            نوفمبر/تشرين الثاني ۲۰۲٤.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Medrol Tablets 4 mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 4 mg methylprednisolone.

Excipients with known effect:
lactose, sucrose

For the full list of excipients, see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Medrol is indicated for conditions requiring glucocorticoid activity such as:‑</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Endocrine disorders</u></p><p>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Primary and secondary adrenal insufficiency</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Congenital adrenal hyperplasia</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Rheumatic disorders</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rheumatoid arthritis</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Juvenile chronic arthritis</p><p>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ankylosing spondylitis</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Collagen diseases/arteritis</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Systemic lupus erythematosus</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Systemic dermatomyositis (polymyositis)</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rheumatic fever with severe carditis</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Giant cell arteritis/polymyalgia rheumatica</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Dermatological diseases</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pemphigus vulgaris</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Allergic states</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe seasonal and perennial allergic rhinitis</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drug hypersensitivity reactions</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Serum sickness&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic contact dermatitis</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bronchial asthma</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Ophthalmic diseases</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anterior uveitis (iritis, iridocyclitis)</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Posterior uveitis</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Optic neuritis</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Respiratory diseases</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pulmonary sarcoid</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fulminating or disseminated tuberculosis (with appropriate anti‑tuberculous chemotherapy)</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aspiration of gastric contents</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Haematological disorders</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Idiopathic thrombocytopenic purpura</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Haemolytic anaemia (autoimmune)</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Neoplastic diseases</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Leukaemia (acute and lymphatic)</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Malignant lymphoma</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Gastro‑intestinal diseases</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ulcerative colitis</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Crohn&#39;s disease</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Miscellaneous</u></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tuberculous meningitis (with appropriate anti-tuberculous chemotherapy)</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transplantation</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The dosage recommendations shown in the table below are suggested initial daily doses and are intended as guides. The average total daily dose recommended may be given either as a single dose or in divided doses (excepting in alternate day therapy when the minimum effective daily dose is doubled and given every other day at 8.00 am).</p><p>&nbsp;</p><p>Undesirable effects may be minimised by using the lowest effective dose for the minimum period (see section 4.4).</p><p>&nbsp;</p><p>The initial suppressive dose level may vary depending on the condition being treated. This is continued until a satisfactory clinical response is obtained, a period usually of three to seven days in the case of rheumatic diseases (except for acute rheumatic carditis), allergic conditions affecting the skin or respiratory tract and ophthalmic diseases. If a satisfactory response is not obtained in seven days, re‑evaluation of the case to confirm the original diagnosis should be made. As soon as a satisfactory clinical response is obtained, the daily dose should be reduced gradually, either to termination of treatment in the case of acute conditions (e.g. seasonal asthma, exfoliative dermatitis, acute ocular inflammations) or to the minimal effective maintenance dose level in the case of chronic conditions (e.g. rheumatoid arthritis, systemic lupus erythematosus, bronchial asthma, atopic dermatitis). In chronic conditions, and in rheumatoid arthritis especially, it is important that the reduction in dosage from initial to maintenance dose levels be accomplished as clinically appropriate. Decrements of not more than 2 mg at intervals of 7 ‑ 10 days are suggested. In rheumatoid arthritis, maintenance steroid therapy should be at the lowest possible level.</p><p>&nbsp;</p><p>In alternate‑day therapy, the minimum daily corticoid requirement is doubled and administered as a single dose every other day at 8.00 am. Dosage requirements depend on the condition being treated and response of the patient.</p><p>&nbsp;</p><p><em>Elderly patients:</em>&nbsp; Treatment of elderly patients, particularly if long‑term, should be planned bearing in mind the more serious consequences of the common side-effects of corticosteroids in old age, particularly osteoporosis, diabetes, hypertension, susceptibility to infection and thinning of skin (see section 4.4).</p><p>&nbsp;</p><p><em>Paediatric population:</em>&nbsp; In general, dosage for children should be based upon clinical response and is at the discretion of the physician. Treatment should be limited to the minimum dosage for the shortest period of time. If possible, treatment should be administered as a single dose on alternate days (see section 4.4).</p><p>&nbsp;</p><p><em>Dosage Recommendations:</em></p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Indications</u> <u>Recommended initial daily dosage</u></p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rheumatoid arthritis</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe 12 ‑ 16 mg</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; moderately severe 8 ‑ 12 mg</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; moderate 4 ‑ 8 mg</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; children 4 ‑ 8 mg</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Systemic dermatomyositis 48 mg</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Systemic lupus erythematosus 20 ‑ 100 mg</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Acute rheumatic fever 48 mg until ESR normal for one week.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic diseases 12 ‑ 40 mg</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bronchial asthma&nbsp; up to 64 mg single dose/alternate day up to 100 mg maximum.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ophthalmic diseases 12 ‑ 40 mg</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Haematological disorders and leukaemias 16 ‑ 100 mg</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Malignant lymphoma 16 - 100 mg</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ulcerative colitis 16 ‑ 60 mg</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Crohn&#39;s disease up to 48 mg per day in acute episodes.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Organ transplantation up to 3.6 mg/kg/day</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pulmonary sarcoid 32 ‑ 48 mg on alternate days.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Giant cell arteritis/polymyalgia rheumatica 64 mg</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pemphigus vulgaris 80 ‑ 360 mg</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Methylprednisolone tablets are contraindicated:
•	in patients who have systemic fungal infections
•	in patients who have systemic infections unless specific anti-infective therapy is employed
•	in patients who have hypersensitivity to the active substance or to any of the excipients listed in section 6.1

Administration of live or live, attenuated vaccines is contraindicated in patients receiving immunosuppressive doses of corticosteroids.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Immunosuppressant Effects/Increased Susceptibility to Infections</strong></p><p>Corticosteroids may increase susceptibility to infection, may mask some signs of infection, and new infections may appear during their use. Suppression of the inflammatory response and immune function increases the susceptibility to fungal, viral and bacterial infections and their severity. The clinical presentation may often be atypical and may reach an advanced stage before being recognised.</p><p><strong>&nbsp;</strong></p><p>Persons who are on drugs which suppress the immune system are more susceptible to infections than healthy individuals. Chicken pox and measles, for example, can have a more serious or even fatal course in non-immune children or adults on corticosteroids.</p><p><strong>&nbsp;</strong></p><p>Chickenpox is of serious concern since this normally minor illness may be fatal in immunosuppressed patients. Patients (or parents of children) without a definite history of chickenpox should be advised to avoid close personal contact with chickenpox or herpes zoster and if exposed they should seek urgent medical attention. Passive immunization with varicella/zoster immunoglobulin (VZIG) is needed by exposed non-immune patients who are receiving systemic corticosteroids or who have used them within the previous 3 months; this should be given within 10 days of exposure to chickenpox. If a diagnosis of chickenpox is confirmed, the illness warrants specialist care and urgent treatment. Corticosteroids should not be stopped and the dose may need to be increased.</p><p>&nbsp;</p><p>Exposure to measles should be avoided. Medical advice must be sought immediately if exposure occurs. Prophylaxis with normal intramuscular immunoglobulin may be needed.</p><p>&nbsp;</p><p>Similarly corticosteroids should be used with great care in patients with known or suspected parasitic infections such as Strongyloides (threadworm) infestation, which may lead to Strongyloides hyperinfection and dissemination with widespread larval migration, often accompanied by severe enterocolitis and potentially fatal gram-negative septicemia.</p><p>&nbsp;</p><p>Administration of live or live, attenuated vaccines is contraindicated in patients receiving immunosuppressive doses of corticosteroids. The antibody response to other vaccines may be diminished.</p><p>&nbsp;</p><p>The use of corticosteroids in active tuberculosis should be restricted to those cases of fulminating or disseminated tuberculosis in which the corticosteroid is used for the management of the disease in conjunction with an appropriate antituberculous regimen. If corticosteroids are indicated in patients with latent tuberculosis or tuberculin reactivity, close observation is necessary as reactivation of the disease may occur. During prolonged corticosteroid therapy, these patients should receive chemoprophylaxis.</p><p>&nbsp;</p><p>Kaposi&rsquo;s sarcoma has been reported to occur in patients receiving corticosteroid therapy. Discontinuation of corticosteroids may result in clinical remission.</p><p>&nbsp;</p><p>The role of corticosteroids in septic shock has been controversial, with early studies reporting both beneficial and detrimental effects.&nbsp; More recently, supplemental corticosteroids have been suggested to be beneficial in patients with established septic shock who exhibit adrenal insufficiency. However, their routine use in septic shock is not recommended. A systematic review of short-course high-dose corticosteroids did not support their use.&nbsp; However, meta-analyses, and a review have suggested that longer courses (5-11 days) of low-dose corticosteroids might reduce mortality.&nbsp;</p><p>&nbsp;</p><p><strong>Immune System</strong></p><p>Because rare instances of skin reactions and anaphylactic/anaphylactoid reactions have occurred in patients receiving corticosteroid therapy, appropriate precautionary measures should be taken prior to administration, especially when the patient has a history of allergy to any drug.</p><p>&nbsp;</p><p>This medicine contains lactose produced from cow&rsquo;s milk. Caution should be exercised in patients with a known or suspected hypersensitivity to cow&rsquo;s milk or its components or other dairy products because it may contain trace amounts of milk ingredients.</p><p><strong>&nbsp;</strong></p><p><strong>Endocrine Effects</strong></p><p>In patients on corticosteroid therapy subjected to unusual stress, increased dosage of rapidly acting corticosteroids before, during, and after the stressful situation is indicated.</p><p>&nbsp;</p><p>Adrenal cortical atrophy develops during prolonged therapy and may persist for months after stopping treatment. In patients who have received more than physiological doses of systemic corticosteroids (approximately 6 mg methylprednisolone) for greater than 3 weeks, withdrawal should not be abrupt. How dose reduction should be carried out depends largely on whether the disease is likely to relapse as the dose of systemic corticosteroids is reduced. Clinical assessment of disease activity may be needed during withdrawal. If the disease is unlikely to relapse on withdrawal of systemic corticosteroids, but there is uncertainty about HPA suppression, the dose of systemic corticosteroid <u>may</u> be reduced rapidly to physiological doses. Once a daily dose of 6 mg methylprednisolone is reached, dose reduction should be slower to allow the HPA-axis to recover.</p><p>&nbsp;</p><p>Abrupt withdrawal of systemic corticosteroid treatment, which has continued up to 3 weeks is appropriate if it considered that the disease is unlikely to relapse. Abrupt withdrawal of doses up to 32 mg daily of methylprednisolone for 3 weeks is unlikely to lead to clinically relevant HPA-axis suppression, in the majority of patients. In the following patient groups, gradual withdrawal of systemic corticosteroid therapy should be considered even after courses lasting 3 weeks or less:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patients who have had repeated courses of systemic corticosteroids, particularly if taken for greater than 3 weeks.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; When a short course has been prescribed within one year of cessation of long-term therapy (months or years).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patients who may have reasons for adrenocortical insufficiency other than exogenous corticosteroid therapy. In addition, acute adrenal insufficiency leading to a fatal outcome may occur if glucocorticoids are withdrawn abruptly.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patients receiving doses of systemic corticosteroid greater than 32 mg daily of methylprednisolone.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patients repeatedly taking doses in the evening.</p><p>&nbsp;</p><p>A steroid &ldquo;withdrawal syndrome,&rdquo; seemingly unrelated to adrenocortical insufficiency, may also occur following abrupt discontinuance of glucocorticoids. This syndrome includes symptoms such as: anorexia, nausea, vomiting, lethargy, headache, fever, joint pain, desquamation, myalgia, weight loss, and/or hypotension. These effects are thought to be due to the sudden change in glucocorticoid concentration rather than to low corticosteroid levels.</p><p>&nbsp;</p><p>Glucocorticoids can produce or aggravate Cushing&rsquo;s syndrome, therefore glucocorticoids should be avoided in patients with Cushing&rsquo;s disease.</p><p>&nbsp;</p><p>Particular care is required when considering the use of systemic corticosteroids in patients with hypothyroidism and frequent patient monitoring is necessary.</p><p>&nbsp;</p><p>Thyrotoxic Periodic Paralysis (TPP) can occur in patients with hyperthyroidism and with methylprednisolone-induced hypokalaemia.</p><p>&nbsp;</p><p>TPP must be suspected in patients treated with methylprednisolone presenting signs or symptoms of muscle weakness, especially in patients with hyperthyroidism.</p><p>&nbsp;</p><p>If TPP is suspected, levels of blood potassium must be immediately monitored and adequately managed to ensure the restoration of normal levels of blood potassium.</p><p><strong>&nbsp;</strong></p><p><strong>Metabolism and Nutrition Disorders</strong></p><p>Corticosteroids, including methylprednisolone, can increase blood glucose, worsen pre-existing diabetes, and predispose those on long-term corticosteroid therapy to diabetes mellitus.</p><p>&nbsp;</p><p>Particular care is required when considering the use of systemic corticosteroids in patients with Diabetes mellitus (or a family history of diabetes) and frequent patient monitoring is necessary.</p><p>&nbsp;</p><p><strong>Psychiatric Effects</strong></p><p>Patients and/or carers should be warned that potentially severe psychiatric adverse reactions may occur with systemic steroids (see section 4.8). Symptoms typically emerge within a few days or weeks of starting treatment. Risks may be higher with high doses/systemic exposure (see also section 4.5), although dose levels do not allow prediction of the onset, type, severity or duration of reactions. Most reactions recover after either dose reduction or withdrawal, although specific treatment may be necessary.</p><p>&nbsp;</p><p>Patients/carers should be encouraged to seek medical advice if worrying psychological symptoms develop, especially if depressed mood or suicidal ideation is suspected. Patients/carers should be alert to possible psychiatric disturbances that may occur either during or immediately after dose tapering/withdrawal of systemic steroids, although such reactions have been reported infrequently.</p><p>&nbsp;</p><p>Particular care is required when considering the use of systemic corticosteroids in patients with existing or previous history of severe affective disorders in themselves or in their first degree relatives. These would include depressive or manic-depressive illness and previous steroid psychosis.</p><p>&nbsp;</p><p><strong>Nervous System Effects</strong></p><p>Particular care is required when considering the use of systemic corticosteroids in patients with seizure disorders and myasthenia gravis (see myopathy statement in Musculoskeletal Effects section) and frequent patient monitoring is necessary.</p><p>&nbsp;</p><p>There have been reports of epidural lipomatosis in patients taking corticosteroids, typically with long-term use at high doses.</p><p>&nbsp;</p><p><strong>Ocular Effects</strong></p><p>Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids. Central serous chorioretinopathy, may lead to retinal detachment.</p><p>&nbsp;</p><p>Particular care is required when considering the use of systemic corticosteroids in patients with glaucoma (or a family history of glaucoma) and ocular herpes simplex as there is a fear of corneal perforation, and frequent patient monitoring is necessary.</p><p>&nbsp;</p><p>Prolonged use of corticosteroids may produce posterior subcapsular cataracts and nuclear cataracts (particularly in children), exophthalmos or increased intraocular pressure, which may result in glaucoma with possible damage to the optic nerves.</p><p>&nbsp;</p><p>Secondary fungal and viral infections of the eye may also be enhanced in patients receiving glucocorticoids.</p><p>&nbsp;</p><p><strong>Cardiac Events</strong></p><p>Adverse effects of glucocorticoids on the cardiovascular system, such as dyslipidemia and hypertension, may predispose treated patients with existing cardiovascular risk factors to additional cardiovascular effects, if high doses and prolonged courses are used. Accordingly, corticosteroids should be employed judiciously in such patients and attention should be paid to risk modification and additional cardiac monitoring if needed. Low dose and alternate day therapy may reduce the incidence of complications in corticosteroid therapy.</p><p>&nbsp;</p><p>Systemic corticosteroids should be used with caution, and only if strictly necessary, in cases of congestive heart failure.</p><p>&nbsp;</p><p>Particular care is required when considering the use of systemic corticosteroids in patients with recent myocardial infarction (myocardial rupture has been reported) and frequent patient monitoring is necessary.</p><p>&nbsp;</p><p>Care should be taken for patients receiving cardioactive drugs such as digoxin because of steroid induced electrolyte disturbance/potassium loss (see section 4.8).</p><p>&nbsp;</p><p><strong>Vascular Effects</strong></p><p>Particular care is required when considering the use of systemic corticosteroids in patients with the following conditions and frequent patient monitoring is necessary.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypertension</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Predisposition to thrombophlebitis</p><p>&nbsp;</p><p>Thrombosis including venous thromboembolism has been reported to occur with corticosteroids. As a result corticosteroids should be used with caution in patients who have or may be predisposed to thromboembolic disorders.</p><p>&nbsp;</p><p><strong>Gastrointestinal Effects</strong></p><p>High doses of corticosteroids may produce acute pancreatitis.</p><p>&nbsp;</p><p>Particular care is required when considering the use of systemic corticosteroids in patients with the following conditions and frequent patient monitoring is necessary.</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Peptic ulceration.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fresh intestinal anastomoses.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abscess or other pyogenic infections.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ulcerative colitis.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diverticulitis.</p><p>&nbsp;</p><p>Glucocorticoid therapy may mask peritonitis or other signs or symptoms associated with gastrointestinal disorders such as perforation, obstruction or pancreatitis. In combination with NSAIDs, the risk of developing gastrointestinal ulcers is increased.</p><p>&nbsp;</p><p><strong>Hepatobiliary Effects</strong></p><p>Particular care is required when considering the use of systemic corticosteroids in patients with liver failure or cirrhosis and frequent patient monitoring is necessary.</p><p>&nbsp;</p><p>Rarely hepatobiliary disorders were reported, in the majority of these cases, they were reversible after withdrawal of therapy. Therefore appropriate monitoring is required.</p><p>&nbsp;</p><p><strong>Musculoskeletal Effects</strong></p><p>An acute myopathy has been reported with the use of high doses of corticosteroids, most often occurring in patients with disorders of neuromuscular transmission (e.g. myasthenia gravis), or in patients receiving concomitant therapy with anticholinergics, such as neuromuscular blocking drugs (e.g. pancuronium). This acute myopathy is generalized, may involve ocular and respiratory muscles, and may result in quadriparesis. Elevations of creatine kinase may occur.&nbsp; Clinical improvement or recovery after stopping corticosteroids may require weeks to years.</p><p>&nbsp;</p><p>Particular care is required when considering the use of systemic corticosteroids in patients with osteoporosis (post-menopausal females are particularly at risk) and frequent patient monitoring is necessary.</p><p>&nbsp;</p><p><strong>Renal and Urinary</strong></p><p>Caution is required in patients with systemic sclerosis because an increased incidence of scleroderma renal crisis has been observed with corticosteroids, including methylprednisolone. Blood pressure and renal function (s-creatinine) should therefore be routinely checked. When renal crisis is suspected, blood pressure should be carefully controlled.</p><p><strong>&nbsp;</strong></p><p>Particular care is required when considering the use of systemic corticosteroids in patients with renal insufficiency and frequent patient monitoring is necessary.</p><p>&nbsp;</p><p><strong>Injury, poisoning and procedural complications</strong></p><p>Systemic corticosteroids are not indicated for, and therefore should not be used to treat, traumatic brain injury,&nbsp; a multicenter study revealed an increased mortality at 2 weeks and 6 months after injury in patients administered methylprednisolone sodium succinate compared to placebo. A causal association with methylprednisolone sodium succinate treatment has not been established.</p><p>&nbsp;</p><p><strong>Other</strong></p><p>Undesirable effects may be minimised by using the lowest effective dose for the minimum period, and by administering the daily requirement as a single morning dose or whenever possible as a single morning dose on alternative days.&nbsp; Frequent patient review is required to appropriately titrate the dose against disease activity (see section 4.2).</p><p>&nbsp;</p><p>Patients should carry &#39;Steroid Treatment&#39; cards which give clear guidance on the precautions to be taken to minimise risk and which provide details of prescriber, drug, dosage and the duration of treatment.</p><p>&nbsp;</p><p>Co-treatment with CYP3A inhibitors, including cobicistat-containing products, is expected to increase the risk of systemic side-effects. The combination should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side-effects, in which case patients should be monitored for systemic corticosteroid side-effects (see section 4.5).</p><p>&nbsp;</p><p>Aspirin and non-steroidal anti-inflammatory agents should be used cautiously in conjunction with corticosteroids.</p><p>&nbsp;</p><p>Pheochromocytoma crisis, which can be fatal, has been reported after administration of systemic corticosteroids. Corticosteroids should only be administered to patients with suspected or identified pheochromocytoma after an appropriate risk/benefit evaluation.</p><p><em>&nbsp;</em></p><p>In post marketing experience tumour lysis syndrome (TLS) has been reported in patients with malignancies, including haematological malignancies and solid tumours, following the use of systemic corticosteroids alone or in combination with other chemotherapeutic agents. Patients at high risk of TLS, such as patients with tumours that have a high proliferative rate, high tumour burden and high sensitivity to cytotoxic agents, should be monitored closely and appropriate precautions should be taken.</p><p><em>&nbsp;</em></p><p><em>Paediatric population:</em>&nbsp; Corticosteroids cause growth retardation in infancy, childhood and adolescence. Growth and development of infants and children on prolonged corticosteroid therapy should be carefully observed. Treatment should be limited to the minimum dosage for the shortest possible time. In order to minimise suppression of the hypothalamo‑pituitary-adrenal axis and growth retardation, treatment should be administered where possible as a single dose on alternate days (see section 4.2).</p><p>&nbsp;</p><p>Infants and children on prolonged corticosteroid therapy are at special risk from raised intracranial pressure.</p><p>High doses of corticosteroids may produce pancreatitis in children.</p><p>&nbsp;</p><p><em>Use in the elderly:</em>&nbsp; The common adverse effects of systemic corticosteroids may be associated with more serious consequences in old age, especially osteoporosis, hypertension, hypokalaemia, diabetes, susceptibility to infection and thinning of the skin. Close clinical supervision is required to avoid life-threatening reactions.</p><p>&nbsp;</p><p><strong>Ingredient warning</strong></p><p>This medicine contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p><p>&nbsp;</p><p>This medicine contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Methylprednisolone is a cytochrome P450 enzyme (CYP) substrate and is mainly metabolized by the CYP3A4 enzyme.&nbsp; CYP3A4 is the dominant enzyme of the most abundant CYP subfamily in the liver of adult humans. It catalyzes 6&beta;-hydroxylation of steroids, the essential Phase I metabolic step for both endogenous and synthetic corticosteroids. Many other compounds are also substrates of CYP3A4, some of which (as well as other drugs) have been shown to alter glucocorticoid metabolism by induction (upregulation) or inhibition of the CYP3A4 enzyme.</p><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:576px"><thead><tr><td><p><strong>Drug Class or Type</strong></p><p><strong>- DRUG or SUBSTANCE</strong></p></td><td><p><strong>Interaction</strong></p></td><td><p><strong>Effect</strong></p></td></tr><tr><td><p>Antibiotic, Antitubercular</p><p>- RIFAMPIN<br />- RIFABUTIN</p></td><td rowspan="3"><p>CYP3A4 Inducer</p></td><td rowspan="3"><p>CYP3A4 INDUCERS - Drugs that induce CYP3A4 activity generally increase hepatic clearance, resulting in decreased plasma concentration of medications that are substrates for CYP3A4. Co-administration may require an increase in methylprednisolone dosage to achieve the desired result.</p></td></tr><tr><td><p>Anticonvulsants</p><p>- PHENOBARBITAL<br />- PHENYTOIN<br />- PRIMIDONE</p></td></tr><tr><td><p>&nbsp;</p></td></tr><tr><td><p>Anticonvulsant</p><p>- CARBAMAZEPINE</p></td><td><p>CYP3A4 Inducer (and Substrate)</p></td><td><p>CYP3A4 INDUCERS &ndash; see box above<br />CYP3A4 SUBSTRATES - In the presence of another CYP3A4 substrate, the hepatic clearance of methylprednisolone may be affected, with corresponding dosage adjustments required. It is possible that adverse events associated with the use of either drug alone may be more likely to occur with co-administration.</p></td></tr><tr><td><p>Macrolide Antibacterial</p><p>- TROLEANDOMYCIN</p></td><td rowspan="5"><p>CYP3A4 Inhibitor</p></td><td rowspan="4"><p>CYP3A4 INHIBITORS - Drugs that inhibit CYP3A4 activity generally decrease hepatic clearance and increase the plasma concentration of CYP3A4 substrate medications, such as methylprednisolone. In the presence of a CYP3A4 inhibitor, the dose of methylprednisolone may need to be titrated to avoid steroid toxicity.</p></td></tr><tr><td><p>- GRAPEFRUIT JUICE</p></td></tr><tr><td><p>Calcium Antagonist</p><p>- MIBEFRADIL</p></td></tr><tr><td><p>Histamine H<sub>2</sub> receptor Antagonist</p><p>- CIMETIDINE</p></td></tr><tr><td><p>Antibacterial</p><p>- ISONIAZID</p></td><td><p>In addition, there is a potential effect of methylprednisolone to increase the acetylation rate and clearance of isoniazid.</p></td></tr><tr><td><p>Antiemetic</p><p>- APREPITANT<br />- FOSAPREPITANT</p></td><td rowspan="7"><p>CYP3A4 Inhibitor (and Substrate)</p></td><td rowspan="7" style="vertical-align:bottom"><p>CYP3A4 INHIBITORS &ndash; see box above<br />CYP3A4 SUBSTRATES - In the presence of another CYP3A4 substrate, the hepatic clearance of methylprednisolone may be affected, with corresponding dosage adjustments required. It is possible that adverse events associated with the use of either drug alone may be more likely to occur with co-administration.<br />&nbsp;</p><p>(1) Mutual inhibition of metabolism occurs with concurrent use of ciclosporin and methylprednisolone, which may increase the plasma concentrations of either or both drugs. Therefore, it is possible that adverse events associated with the use of either drug alone may be more likely to occur upon co-administration.<br />&nbsp;</p><p>(2) Protease inhibitors, such as indinavir and ritonavir, may increase plasma concentrations of corticosteroids.<br /><br />(3) Corticosteroids may induce the metabolism of HIV-protease inhibitors resulting in reduced plasma concentrations.</p></td></tr><tr><td><p>Antifungal</p><p>- ITRACONAZOLE<br />- KETOCONAZOLE</p></td></tr><tr><td><p>Calcium Channel Blocker</p><p>- DILTIAZEM</p></td></tr><tr><td><p>Contraceptives (oral)</p><p>- ETHINYLESTRADIOL/ NORETHINDRONE</p></td></tr><tr><td><p>Immunosuppressant</p><p>- CICLOSPORIN (1)</p></td></tr><tr><td><p>Macrolide Antibacterial</p><p>- CLARITHROMYCIN<br />- ERYTHROMYCIN</p></td></tr><tr><td style="vertical-align:top"><p>Antivirals</p><p>- HIV-PROTEASE INHIBITORS (2) (3)</p><p>Pharmacokinetic enhancers</p><p>&nbsp;&nbsp;&nbsp; -COBICISTAT</p></td></tr><tr><td><p>Immunosuppressant</p><p>- CYCLOPHOSPHAMIDE<br />- TACROLIMUS</p></td><td><p>CYP3A4 Substrate</p></td><td><p>CYP3A4 SUBSTRATES - In the presence of another CYP3A4 substrate, the hepatic clearance of methylprednisolone may be affected, with corresponding dosage adjustments required. It is possible that adverse events associated with the use of either drug alone may be more likely to occur with co-administration.</p></td></tr><tr><td><p>NSAIDs (nonsteroidal anti-inflammatory drugs) (4)</p><p>- high-dose ASPIRIN (5)<br />(acetylsalicylic acid)</p></td><td rowspan="7"><p>Non-CYP3A4-mediated effects</p></td><td><p>(4) There may be increased incidence of gastrointestinal bleeding and ulceration when corticosteroids are given with NSAIDs.</p><p>(5) Methylprednisolone may increase the clearance of high-dose aspirin, which can lead to decreased salicylate serum levels. Discontinuation of methylprednisolone treatment can lead to raised salicylate serum levels, which could lead to an increased risk of salicylate toxicity.</p></td></tr><tr><td><p>Anticholinergics (6)</p><p>- NEUROMUSCULAR BLOCKERS (7)</p></td><td><p>(6) An acute myopathy has been reported with the concomitant use of high doses of corticosteroids and anticholinergics, such as neuromuscular blocking drugs. (See section 4.4 Musculoskeletal, for additional information.)</p><p>(7) Antagonism of the neuromuscular blocking effects of pancuronium and vecuronium has been reported in patients taking corticosteroids. This interaction may be expected with all competitive neuromuscular blockers.</p></td></tr><tr><td><p>Anticholinesterases</p></td><td><p>Steroids may reduce the effects of anticholinesterases in myasthenia gravis.</p></td></tr><tr><td><p>Anti-diabetics</p></td><td><p>Because corticosteroids may increase blood glucose concentrations, dosage adjustments of anti-diabetic agents may be required.</p></td></tr><tr><td><p>Anticoagulants (oral)</p></td><td><p>The efficacy of coumarin anticoagulants may be enhanced by concurrent corticosteroid therapy and close monitoring of the INR or prothrombin time is required to avoid spontaneous bleeding.</p></td></tr><tr><td><p>Potassium-depleting agents</p></td><td><p>When corticosteroids are administered concomitantly with potassium-depleting agents (i.e. diuretics), patients should be observed closely for development of hypokalaemia. There is also an increased risk of hypokalaemia with concurrent use of corticosteroids with amphotericin B, xanthenes, or beta2 agonists.</p></td></tr><tr><td><p>Aromatase inhibitors</p><p>-AMINOGLUTETHIMIDE</p></td><td><p>Aminoglutethimide-induced adrenal suppression may exacerbate endocrine changes caused by prolonged glucocorticoid treatment.</p></td></tr></thead></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Methylprednisolone is a cytochrome P450 enzyme (CYP) substrate and is mainly metabolized by the CYP3A4 enzyme.&nbsp; CYP3A4 is the dominant enzyme of the most abundant CYP subfamily in the liver of adult humans. It catalyzes 6&beta;-hydroxylation of steroids, the essential Phase I metabolic step for both endogenous and synthetic corticosteroids. Many other compounds are also substrates of CYP3A4, some of which (as well as other drugs) have been shown to alter glucocorticoid metabolism by induction (upregulation) or inhibition of the CYP3A4 enzyme.</p><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:576px"><thead><tr><td><p><strong>Drug Class or Type</strong></p><p><strong>- DRUG or SUBSTANCE</strong></p></td><td><p><strong>Interaction</strong></p></td><td><p><strong>Effect</strong></p></td></tr><tr><td><p>Antibiotic, Antitubercular</p><p>- RIFAMPIN<br />- RIFABUTIN</p></td><td rowspan="3"><p>CYP3A4 Inducer</p></td><td rowspan="3"><p>CYP3A4 INDUCERS - Drugs that induce CYP3A4 activity generally increase hepatic clearance, resulting in decreased plasma concentration of medications that are substrates for CYP3A4. Co-administration may require an increase in methylprednisolone dosage to achieve the desired result.</p></td></tr><tr><td><p>Anticonvulsants</p><p>- PHENOBARBITAL<br />- PHENYTOIN<br />- PRIMIDONE</p></td></tr><tr><td><p>&nbsp;</p></td></tr><tr><td><p>Anticonvulsant</p><p>- CARBAMAZEPINE</p></td><td><p>CYP3A4 Inducer (and Substrate)</p></td><td><p>CYP3A4 INDUCERS &ndash; see box above<br />CYP3A4 SUBSTRATES - In the presence of another CYP3A4 substrate, the hepatic clearance of methylprednisolone may be affected, with corresponding dosage adjustments required. It is possible that adverse events associated with the use of either drug alone may be more likely to occur with co-administration.</p></td></tr><tr><td><p>Macrolide Antibacterial</p><p>- TROLEANDOMYCIN</p></td><td rowspan="5"><p>CYP3A4 Inhibitor</p></td><td rowspan="4"><p>CYP3A4 INHIBITORS - Drugs that inhibit CYP3A4 activity generally decrease hepatic clearance and increase the plasma concentration of CYP3A4 substrate medications, such as methylprednisolone. In the presence of a CYP3A4 inhibitor, the dose of methylprednisolone may need to be titrated to avoid steroid toxicity.</p></td></tr><tr><td><p>- GRAPEFRUIT JUICE</p></td></tr><tr><td><p>Calcium Antagonist</p><p>- MIBEFRADIL</p></td></tr><tr><td><p>Histamine H<sub>2</sub> receptor Antagonist</p><p>- CIMETIDINE</p></td></tr><tr><td><p>Antibacterial</p><p>- ISONIAZID</p></td><td><p>In addition, there is a potential effect of methylprednisolone to increase the acetylation rate and clearance of isoniazid.</p></td></tr><tr><td><p>Antiemetic</p><p>- APREPITANT<br />- FOSAPREPITANT</p></td><td rowspan="7"><p>CYP3A4 Inhibitor (and Substrate)</p></td><td rowspan="7" style="vertical-align:bottom"><p>CYP3A4 INHIBITORS &ndash; see box above<br />CYP3A4 SUBSTRATES - In the presence of another CYP3A4 substrate, the hepatic clearance of methylprednisolone may be affected, with corresponding dosage adjustments required. It is possible that adverse events associated with the use of either drug alone may be more likely to occur with co-administration.<br />&nbsp;</p><p>(1) Mutual inhibition of metabolism occurs with concurrent use of ciclosporin and methylprednisolone, which may increase the plasma concentrations of either or both drugs. Therefore, it is possible that adverse events associated with the use of either drug alone may be more likely to occur upon co-administration.<br />&nbsp;</p><p>(2) Protease inhibitors, such as indinavir and ritonavir, may increase plasma concentrations of corticosteroids.<br /><br />(3) Corticosteroids may induce the metabolism of HIV-protease inhibitors resulting in reduced plasma concentrations.</p></td></tr><tr><td><p>Antifungal</p><p>- ITRACONAZOLE<br />- KETOCONAZOLE</p></td></tr><tr><td><p>Calcium Channel Blocker</p><p>- DILTIAZEM</p></td></tr><tr><td><p>Contraceptives (oral)</p><p>- ETHINYLESTRADIOL/ NORETHINDRONE</p></td></tr><tr><td><p>Immunosuppressant</p><p>- CICLOSPORIN (1)</p></td></tr><tr><td><p>Macrolide Antibacterial</p><p>- CLARITHROMYCIN<br />- ERYTHROMYCIN</p></td></tr><tr><td style="vertical-align:top"><p>Antivirals</p><p>- HIV-PROTEASE INHIBITORS (2) (3)</p><p>Pharmacokinetic enhancers</p><p>&nbsp;&nbsp;&nbsp; -COBICISTAT</p></td></tr><tr><td><p>Immunosuppressant</p><p>- CYCLOPHOSPHAMIDE<br />- TACROLIMUS</p></td><td><p>CYP3A4 Substrate</p></td><td><p>CYP3A4 SUBSTRATES - In the presence of another CYP3A4 substrate, the hepatic clearance of methylprednisolone may be affected, with corresponding dosage adjustments required. It is possible that adverse events associated with the use of either drug alone may be more likely to occur with co-administration.</p></td></tr><tr><td><p>NSAIDs (nonsteroidal anti-inflammatory drugs) (4)</p><p>- high-dose ASPIRIN (5)<br />(acetylsalicylic acid)</p></td><td rowspan="7"><p>Non-CYP3A4-mediated effects</p></td><td><p>(4) There may be increased incidence of gastrointestinal bleeding and ulceration when corticosteroids are given with NSAIDs.</p><p>(5) Methylprednisolone may increase the clearance of high-dose aspirin, which can lead to decreased salicylate serum levels. Discontinuation of methylprednisolone treatment can lead to raised salicylate serum levels, which could lead to an increased risk of salicylate toxicity.</p></td></tr><tr><td><p>Anticholinergics (6)</p><p>- NEUROMUSCULAR BLOCKERS (7)</p></td><td><p>(6) An acute myopathy has been reported with the concomitant use of high doses of corticosteroids and anticholinergics, such as neuromuscular blocking drugs. (See section 4.4 Musculoskeletal, for additional information.)</p><p>(7) Antagonism of the neuromuscular blocking effects of pancuronium and vecuronium has been reported in patients taking corticosteroids. This interaction may be expected with all competitive neuromuscular blockers.</p></td></tr><tr><td><p>Anticholinesterases</p></td><td><p>Steroids may reduce the effects of anticholinesterases in myasthenia gravis.</p></td></tr><tr><td><p>Anti-diabetics</p></td><td><p>Because corticosteroids may increase blood glucose concentrations, dosage adjustments of anti-diabetic agents may be required.</p></td></tr><tr><td><p>Anticoagulants (oral)</p></td><td><p>The efficacy of coumarin anticoagulants may be enhanced by concurrent corticosteroid therapy and close monitoring of the INR or prothrombin time is required to avoid spontaneous bleeding.</p></td></tr><tr><td><p>Potassium-depleting agents</p></td><td><p>When corticosteroids are administered concomitantly with potassium-depleting agents (i.e. diuretics), patients should be observed closely for development of hypokalaemia. There is also an increased risk of hypokalaemia with concurrent use of corticosteroids with amphotericin B, xanthenes, or beta2 agonists.</p></td></tr><tr><td><p>Aromatase inhibitors</p><p>-AMINOGLUTETHIMIDE</p></td><td><p>Aminoglutethimide-induced adrenal suppression may exacerbate endocrine changes caused by prolonged glucocorticoid treatment.</p></td></tr></thead></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The effect of corticosteroids on the ability to drive or use machinery has not been systematically evaluated. Undesirable effects, such as dizziness, vertigo, visual disturbances and fatigue are possible after treatment with corticosteroids. If affected, patients should not drive or operate machinery.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td><p><strong>System Organ Class</strong></p><p>&nbsp;</p></td><td><p><strong>Frequency&dagger;</strong></p></td><td><p><strong>Undesirable Effects</strong></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong><em>Infections and infestations</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Common</em></strong></p></td><td style="vertical-align:top"><p>Infection (including increased susceptibility and severity of infections with suppression of clinical symptoms and signs)</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Opportunistic infection; recurrence of dormant tuberculosis, Peritonitis&dagger;</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Blood and lymphatic system disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Leukocytosis</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Immune system disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Drug hypersensitivity</p><p>Anaphylactic reaction</p><p>Anaphylactoid reaction</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong><em>Endocrine disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Common</em></strong></p></td><td style="vertical-align:top"><p>Cushingoid</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Hypothalamic pituitary adrenal axis suppression</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Neoplasms benign, malignant and unspecified (including cysts and polyps)</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Kaposi&rsquo;s sarcoma</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong><em>Metabolism and nutrition disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Common</em></strong></p></td><td style="vertical-align:top"><p>Sodium retention; Fluid retention</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Metabolic acidosis ;Alkalosis hypokalaemic; Dyslipidaemia; Glucose tolerance impaired; increased requirements for insulin (or oral hypoglycemic agents in diabetics); Lipomatosis;; Increased appetite (which may result in Weight increased); Epidural lipomatosis</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong><em>Psychiatric disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Common</em></strong></p></td><td style="vertical-align:top"><p>Affective disorder (including Depressed mood and Euphoric mood)</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Psychotic disorder (including Mania, Delusion, Hallucination, and Schizophrenia;&nbsp; Psychotic behaviour; Affective disorder (including Affect lability, Psychological dependence, Suicidal ideation); Mental disorder; Personality change; Confusional state;&nbsp; Anxiety; Mood swings; Abnormal behaviour; Insomnia; Irritability</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Nervous system disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Intracranial pressure increased (with Papilloedema [Benign intracranial hypertension]); Seizure; Amnesia; Cognitive disorder; Dizziness; Headache</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong><em>Eye disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Common </em></strong></p></td><td style="vertical-align:top"><p>Cataract</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Rare</em></strong></p></td><td style="vertical-align:top"><p>Vision blurred (see also section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Glaucoma; Exophthalmos; Corneal thinning; Scleral thinning; Chorioretinopathy</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Ear and labyrinth disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Vertigo</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Cardiac disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Cardiac failure congestive (in susceptible patients); Myocardial rupture following myocardial infarction</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong><em>Vascular disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Common</em></strong></p></td><td style="vertical-align:top"><p>Hypertension</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Hypotension; Embolism arterial; Thrombotic events; Flushing</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Respiratory, thoracic and mediastinal disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Pulmonary embolism, Hiccups</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong><em>Gastrointestinal disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Common</em></strong></p></td><td style="vertical-align:top"><p>Peptic ulcer (with possible Peptic ulcer perforation and Peptic ulcer haemorrhage)</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Intestinal perforation; Gastric haemorrhage; Pancreatitis; Oesophagitis ulcerative; Oesophagitis;Abdominal distension; Abdominal pain; Diarrhoea; Dyspepsia; Nausea</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Hepatobiliary disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Increase of liver enzymes (e.g alanine aminotransferase increased, aspartate aminotransferase increased)</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong><em>Skin and subcutaneous tissue disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Common</em></strong></p></td><td style="vertical-align:top"><p>Skin atrophy; Acne</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Angioedema; Hirsutism; Petechiae; Ecchymosis; Erythema; Hyperhidrosis; Skin striae; Rash Pruritus; Urticaria; Telangiectasia</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong><em>Musculoskeletal and connective tissue disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Common</em></strong></p></td><td style="vertical-align:top"><p>Muscular weakness; Growth retardation</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Myalgia; Myopathy; Muscle atrophy; Osteoporosis; Osteonecrosis; Pathologic fracture; Neuropathic arthropathy; Arthralgia;</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Reproductive system and breast disorders</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Menstruation irregular</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong><em>General disorders and administration site conditions</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Common</em></strong></p></td><td style="vertical-align:top"><p>Impaired healing</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Oedema peripheral<sup> </sup>;Fatigue; Malaise; Withdrawal symptoms - too rapid a reduction of corticosteroid dosage following prolonged treatment can lead to acute adrenal insufficiency, hypotension and death (see section 4.4)</p><p>&nbsp;</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong><em>Investigations</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Common</em></strong></p></td><td style="vertical-align:top"><p>Blood potassium decreased</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Intraocular pressure increased; Carbohydrate tolerance decreased; Urine calcium increased Blood alkaline phosphatase increased; Blood urea increased; Suppression of reactions to skin tests<sup>*</sup></p></td></tr><tr><td style="vertical-align:top"><p><strong><em>Injury, poisoning and procedural complications</em></strong></p></td><td style="vertical-align:top"><p><strong><em>Not Known</em></strong></p></td><td style="vertical-align:top"><p>Tendon rupture (particularly of the Achilles tendon); Spinal compression fracture</p></td></tr></tbody></table><p>&nbsp;</p><p>* Not a MedDRA PT</p><p>&nbsp;</p><p><sup>&dagger; </sup>Peritonitis may be the primary presenting sign or symptom of a gastrointestinal disorder such as perforation, obstruction or pancreatitis (see section 4.4)</p><p>&nbsp;</p><p>Common (&ge;1/100 to &lt;1/10); Uncommon (&ge;1/1,000 to &lt;1/100); Rare (&ge;1/10,000 to &lt;1/1,000); Not known (frequency cannot be estimated from the available data)</p><p>&nbsp;</p><p>The incidence of predictable undesirable side-effects associated with the use of corticosteroids, including hypothalamic-pituitary-adrenal suppression correlates with the relative potency of the drug, dosage, timing of administration and duration of treatment (see section 4.4).</p><p>&nbsp;</p><p><strong>Reporting of suspected adverse reactions</strong><br />Reporting suspected adverse reactions after marketing authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions according to their local requirements.</p><p>&nbsp;</p><p><strong>To Report side effects</strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia:</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>National Pharmacovigilance Center (NPC)</strong></p><p>Call center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other</strong><strong> GCC States</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Administration of methylprednisolone should not be discontinued abruptly but tailed off over a period of time. Appropriate action should be taken to alleviate the symptoms produced by any side-effect that may become apparent. It may be necessary to support the patient with corticosteroids during any further period of trauma occurring within two years of overdosage.</p><p>&nbsp;</p><p>There is no clinical syndrome of acute overdose with methylprednisolone. Reports of acute toxicity and/or death following overdosage of glucocorticoids are rare. In the event of overdosage, no specific antidote is available; treatment is supportive and symptomatic. Methylprednisolone is haemodialysable.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Glucocorticosteroids, ATC Code H02AB04</p><p>Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system.</p><p>&nbsp;</p><p>Glucocorticoids act primarily by binding to and activating intracellular glucocorticoid receptors. Activated glucocorticoid receptors bind to promoter regions of DNA (which may activate or suppress transcription) and activate transcription factors resulting in inactivation of genes through de-acetylation of histones.</p><p>&nbsp;</p><p>Following corticosteroid administration there is a delay of several hours for the clinical effects resulting from changes in gene expression to be seen.</p><p>Other effects not related to gene expression may be more immediate.</p><p>&nbsp;</p><p>Corticosteroids influence the kidney and fluid and electrolyte balance, lipid, protein, and carbohydrate metabolism, skeletal muscle, the cardiovascular system, the immune system, the nervous system, and the endocrine system. Corticosteroids are also critical in the maintenance of function during stress.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Methylprednisolone pharmacokinetics is linear, independent of route of administration.</p><p>&nbsp;</p><p><u>Absorption:</u></p><p>Methylprednisolone is rapidly absorbed and the maximum plasma methylprednisolone concentration is achieved around 1.5 to 2.3 hours across doses following oral administration in normal healthy adults. The absolute bioavailability of methylprednisolone in normal healthy subjects is generally high (82% to 89%) following oral administration.</p><p>&nbsp;</p><p><u>Distribution:</u></p><p>Methylprednisolone is widely distributed into the tissues, crosses the blood-brain barrier, and is secreted in breast milk. Its apparent volume of distribution is approximately 1.4 L/kg.</p><p>&nbsp;</p><p>The plasma protein binding of methylprednisolone in humans is approximately 77%.</p><p>&nbsp;</p><p><u>Metabolism:</u></p><p>Corticosteroids are metabolised mainly in the liver but also in the kidney and are excreted in the urine.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;</p><p>In humans, methylprednisolone is metabolized in the liver to inactive metabolites; the major ones are 20&alpha;-hydroxymethylprednisolone and 20&beta;-hydroxymethylprednisolone.</p><p>Metabolism in the liver occurs primarily via the CYP3A4 enzyme. (For a list of drug interactions based on CYP3A4-mediated metabolism, see section 4.5.)</p><p>&nbsp;</p><p>Methylprednisolone, like many CYP3A4 substrates, may also be a substrate for the ATP-binding cassette (ABC) transport protein p-glycoprotein, influencing tissue distribution and interactions with other medicines.</p><p>&nbsp;</p><p><u>Elimination:</u></p><p>The mean elimination half-life for total methylprednisolone is in the range of 1.8 to 5.2 hours. Total clearance is approximately 5 to 6 mL/min/kg.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Based on conventional studies of safety pharmacology and repeated dose toxicity, no unexpected hazards were identified. The toxicities seen in repeated-dose studies were those expected to occur with continued exposure to exogenous adrenocortical steroids.</p><p>&nbsp;</p><p>Mutagenic potential:</p><p>Methylprednisolone has not been formally evaluated for genotoxicity. Studies using structurally related analogues of methylprednisolone showed no evidence of a potential for genetic and chromosome mutations in limited studies in bacteria and mammalian cells.</p><p>&nbsp;</p><p>Carcinogenic potential:</p><p>Methylprednisolone has not been formally evaluated in rodent carcinogenicity studies. Variable results have been obtained with other glucocorticoids tested for carcinogenicity in mice and rats. However, published data indicate that several related glucocorticoids including budesonide, prednisolone, and triamcinolone acetonide can increase the incidence of hepatocellular adenomas and carcinomas after oral administration in drinking water to male rats. These tumorigenic effects occurred at doses which were less than the typical clinical doses on a mg/m<sup>2</sup> basis. The clinical relevance of these findings is unknown.</p><p>&nbsp;</p><p>Reproductive toxicity:</p><p>Methylprednisolone has not been evaluated in animal fertility studies. Adverse effects on fertility in male rats administered corticosterone were observed and were reversible. Decreased weights and microscopic changes in prostate and seminal vesicles were observed. The numbers of implantations and live fetuses were reduced and these effects were not present following mating at the end of the recovery period.</p><p>&nbsp;</p><p>An increased frequency of cleft palate was observed among the offspring of mice treated during pregnancy with methylprednisolone in doses similar to those typically used for oral therapy in humans.</p><p>&nbsp;</p><p>An increased frequency of cardiovascular defects and decreased body weight were observed among the offspring of pregnant rats treated with methylprednisolone in a dose that was similar to that used for oral therapy in humans but was toxic to the mothers. In contrast, no teratogenic effect was noted in rats with doses &lt;1-18 times those typically used or oral therapy in humans in another study. High frequencies of foetal death and a variety of central nervous system and skeletal anomalies were reported in the offspring of pregnant rabbits treated with methylprednisolone in doses less than those used in humans. The relevance of these findings to the risk of malformations in human infants born to mothers treated with methylprednisolone in pregnancy is unknown. Safety margins for the reported teratogenic effects are unknown.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lactose</p><p>Sucrose</p><p>Maize starch</p><p>Calcium stearate</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
Do not use Medrol after the expiry date which is stated on the carton / Blister after EXP:. The expiry date refers to the last day of that month.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>High density polyethylene bottles with tamper evident caps. Each bottle contains 30 tablets.</p><p>&nbsp;</p><p>Medrol Tablets 4 mg are half oval, elliptical, white tablets debossed &ldquo;Medrol 4&rdquo; on one side and double scored on the other side.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep out of the sight and reach of children.</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>&nbsp;</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MARKETING AUTHORISATION HOLDER:
Pfizer Italia S.r.l, Via Isonzo, 71-04100, Latina, Italy 

Manufacturer, Package and Released By:
Pfizer Italia S.r.l, Localita Marino del Tronto, 63100 Ascoli Piceno (AP), Italy

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                November 2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>